pubmed_id,title,journal,year,authors,affiliations,has_pharma_author
40746212,Novel Carrier-Free Nanomedicine for Regulating Macrophage Phenotype to Amplify Anti-Tumor Photoimmunotherapy.,"Small (Weinheim an der Bergstrasse, Germany)",2025,Jingfeng Xiang; Meng Suo; Jiangli Lan; Shipeng Ning; Huan Liu; Wei Hong; Jing Liang; Jianqiu Zheng; Daoming Zhu; Jianlan Mo,"Department of General Surgery, Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China.; School of Biomedical Engineering, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, 511436, China.; Department of Anesthesiology, Maternity and Child Health Care of Guangxi Zhuang Autonomous Region, Nanning, 537500, China.; Department of Breast Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530000, China.; Department of Anesthesiology, Maternity and Child Health Care of Guangxi Zhuang Autonomous Region, Nanning, 537500, China.; Department of Anesthesiology, Maternity and Child Health Care of Guangxi Zhuang Autonomous Region, Nanning, 537500, China.; Department of Breast Surgery, Maternity and Child Health Care of Guangxi Zhuang Autonomous Region, Nanning, 530002, China.; Department of Anesthesiology, Maternity and Child Health Care of Guangxi Zhuang Autonomous Region, Nanning, 537500, China.; Department of General Surgery, Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China.; Department of Anesthesiology, Maternity and Child Health Care of Guangxi Zhuang Autonomous Region, Nanning, 537500, China.",False
40745160,Mogat1 drives metabolic adaptations to evade immune surveillance.,Nature communications,2025,Huan Wei; Congyi Niu; Yue Shi; Yingfei Fang; Chengheng Yang; Jian Liu; Zhenjie Xu,"School of Basic Medical Science, Fudan University, Shanghai, China.; School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China.; School of Basic Medical Science, Fudan University, Shanghai, China.; School of Life Sciences, Fudan University, Shanghai, China.; Westlake University Research Center for Industries of the Future, Westlake University, Hangzhou, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China.; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.; Department of Breast Surgery, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang, China.; School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China. xuzhenjie@westlake.edu.cn.; School of Life Sciences, Fudan University, Shanghai, China. xuzhenjie@westlake.edu.cn.; Westlake University Research Center for Industries of the Future, Westlake University, Hangzhou, Zhejiang, China. xuzhenjie@westlake.edu.cn.; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China. xuzhenjie@westlake.edu.cn.; School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. xuzhenjie@westlake.edu.cn.",False
40744813,"Proteomic Analysis Identifies Association of Periostin, a Matricellular Protein, with High Tumor Stroma and Immune Exclusion in Triple-Negative Breast Cancer.",Cancer research and treatment,2025,Yeonjin Jeon; GunHee Lee; Byung-Kwan Jeong; Yoon Young Kim; JiSun Kim; Jae Ho Jeong; Kyunggon Kim; Hee Jin Lee,"Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.; Department of Diagnostic Pathology, Samkwang Medical Laboratories, Seoul, Korea.; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.; Department of Digital Medicine, University of Ulsan College of Medicine, Seoul, Korea.; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.; NeogenTC Corp., Seoul, Korea.",True
40744683,Co-Expression of MHC-II and ANXA1: Mediators of PD-1/PD-L1 Therapy Resistance in Breast Cancer.,"Cancer reports (Hoboken, N.J.)",2025,Hao Wang; Ji-Feng Sun; Chen Wang; Zhan-Sheng Jiang; Zhong-Sheng Tong,"Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin Cancer Hospital Airport Hospital, Tianjin, China.; Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Tianjin Cancer Hospital Airport Hospital, Tianjin, China.; Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.",False
40744660,MIAT promotes tumor-infiltrating CD8+ T-cell exhaustion and malignant progression of renal cell carcinoma via activating JAK3/STAT3 pathway.,Journal for immunotherapy of cancer,2025,Ming-Xiao Zhang; Lan-Yu Jing; Hao-Tian Tan; Zi-Ran Dai; Da-Zhi Long; Han-Chao Liu; An-Ze Yu; Bin Wang; Zi-Yin Chen; Jun-Hang Luo; Zhen-Hua Chen; Jian-Feng Wang,"Department of Urology, China-Japan Friendship Hospital, Beijing, China.; Breast Department, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Academy of Medical Sciences, Guangzhou, China.; Department of Urology, China-Japan Friendship Hospital, Beijing, China.; Department of Urology, China-Japan Friendship Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.; Department of Urology, Ji'an Center People's Hospital, Ji'an, China.; Department of Andrology and Urology, Sir Run Run Shaw Hospital, affiliated with the Zhejiang University School of Medicine, Hangzhou, China.; Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.; Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; Department of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.; Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China zryywjf@163.com chenzhh75@mail.sysu.edu.cn.; Department of Urology, China-Japan Friendship Hospital, Beijing, China zryywjf@163.com chenzhh75@mail.sysu.edu.cn.",False
40741879,Artificial Intelligence and the Evolving Landscape of Immunopeptidomics.,Proteomics. Clinical applications,2025,Thanh Hoa Vo; Edel McNeela; Orla O'Donovan; Sweta Rani; Jai Prakash Mehta,"Department of Science, Pharmaceutical and Molecular Biotechnology Research Center (PMBRC), South East Technological University, Waterford, Ireland.; Department of Science, Pharmaceutical and Molecular Biotechnology Research Center (PMBRC), South East Technological University, Waterford, Ireland.; Department of Science, Pharmaceutical and Molecular Biotechnology Research Center (PMBRC), South East Technological University, Waterford, Ireland.; Department of Science, Pharmaceutical and Molecular Biotechnology Research Center (PMBRC), South East Technological University, Waterford, Ireland.; Department of Applied Science, South East Technological University, Carlow, Ireland.",False
40740766,Systematic analysis of ZDHHC9 as a potential prognostic and immunotherapy biomarker in breast cancer.,Frontiers in immunology,2025,Desheng Zhou; Zhenpeng Wu; Yachao Cui; Doudou Wang; Hejun Song; Jun Chen; Hong Lin,"The Sixth School of Clinical Medicine, The Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, China.; Guangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, China.; The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou, China.; Guangzhou National Laboratory, Guangzhou, China.; Shaanxi Energy Institute, Shaanxi, China.; Guangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, China.; Thyroid and Breast Surgery Department, Shenzhen Hospital, Southern Medicaid University, Shenzhen, China.; The Sixth School of Clinical Medicine, The Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, China.",False
40738541,B-cell editing: An emerging alternative of precision oncotherapy.,Advances in immunology,2025,Pritha Roy Choudhury; Mohona Chakravarti; Saptak Banerjee; Rathindranath Baral; Anamika Bose,"Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute (CNCI), Kolkata, India.; Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.; Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute (CNCI), Kolkata, India.; Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute (CNCI), Kolkata, India.; Department of Pharmaceutical Technology (Biotechnology), National Institute of Pharmaceutical Education and Research (NIPER), SAS Nagar, Punjab, India. Electronic address: boseanamika@niper.ac.in.",False
40738175,Augmenting cGAS/STING-mediated innate immunity by copper-based nanoplatform for synergistic cancer immunotherapy via inducing irreversible DNA damage.,Journal of controlled release : official journal of the Controlled Release Society,2025,Zhenhao Li; Hongwu Chen; Chubin Wang; Tingting Deng; Jiehao Huang; Haixuan Ye; Jiajia Chen; Cong Huang; Zhian Chen,"The First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China; The First Clinical Medical College, Southern Medical University, Guangzhou 510515, China.; The First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China.; The First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China.; The First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China.; The First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China.; The First Clinical Medical College, Southern Medical University, Guangzhou 510515, China; Chaozhou Central Hospital, Chaozhou, 521000, China.; Chaozhou Central Hospital, Chaozhou, 521000, China. Electronic address: 81718370@qq.com.; The First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China. Electronic address: chuang200628@163.com.; Zhongshan City People's Hospital, Zhongshan, 528403, China. Electronic address: 877676698@qq.com.",False
40737412,Morphology- and adhesion-dual biomimetic nanovaccine boosts antigen cross-presentation through subcellular transport regulation.,Science advances,2025,Zhenyu Wang; Huimin Zhou; Qianyi Su; Qinyu Qiu; Wenjia Deng; Miaomiao Zhang; Zhiyong Xu; Jiaxin Li; Jisheng Xiao; Xiaopin Duan,"Department of General Surgery, Zhujiang Hospital; Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.; Translational Medicine Research Center, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.; Department of General Surgery, Zhujiang Hospital; Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.; Department of General Surgery, Zhujiang Hospital; Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.; Translational Medicine Research Center, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.; Department of General Surgery, Zhujiang Hospital; Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.; Department of General Surgery, Zhujiang Hospital; Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.; Department of General Surgery, Zhujiang Hospital; Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.; Department of General Surgery, Zhujiang Hospital; Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.; Department of General Surgery, Zhujiang Hospital; Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.; Translational Medicine Research Center, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.; Department of General Surgery, Zhujiang Hospital; Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.",False
40736162,Baseline and Early Treatment MRI Model for Predicting Complete Pathologic Response to Neoadjuvant Chemoimmunotherapy in Patients With Triple-Negative Breast Cancer.,AJR. American journal of roentgenology,2025,Bin Liu; Lei Wu; Chunling Liu; Xiaoyu Long; Shan Hu; Linyu Zhang; Zaiyi Liu; Changhong Liang,"Department of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; Department of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.; Department of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; Department of Pathology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.; Department of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.; Department of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.; Department of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.",False
40735962,Self-Delivery Nanotherapeutics for Tumor Low-Temperature Photothermal Immunotherapy through Cascade Heat Shock Protein and Inflammation Inhibition.,ACS applied materials & interfaces,2025,Xiaoliang Deng; Xianquan Feng; Xiaohui Tang; Zhihui Zheng; Da Zheng; Enqin Zheng; Lingjun Zeng; Shiying Xu; Boxin Chen; Qian Zhang; Zhihong Liu; Hongtao Song,"School of Pharmacy, Fujian University of Chinese Traditional Medicine, Fuzhou 350122, China.; 900th Hospital of PLA Joint Logistic Support Force, Fuzhou 350025, China.; School of Pharmacy, Fujian University of Chinese Traditional Medicine, Fuzhou 350122, China.; 900th Hospital of PLA Joint Logistic Support Force, Fuzhou 350025, China.; School of Pharmacy, Fujian University of Chinese Traditional Medicine, Fuzhou 350122, China.; School of Pharmacy, Fujian University of Chinese Traditional Medicine, Fuzhou 350122, China.; 900th Hospital of PLA Joint Logistic Support Force, Fuzhou 350025, China.; School of Pharmacy, Fujian University of Chinese Traditional Medicine, Fuzhou 350122, China.; 900th Hospital of PLA Joint Logistic Support Force, Fuzhou 350025, China.; School of Pharmacy, Fujian University of Chinese Traditional Medicine, Fuzhou 350122, China.; 900th Hospital of PLA Joint Logistic Support Force, Fuzhou 350025, China.; 900th Hospital of PLA Joint Logistic Support Force, Fuzhou 350025, China.; 900th Hospital of PLA Joint Logistic Support Force, Fuzhou 350025, China.; School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.; 900th Hospital of PLA Joint Logistic Support Force, Fuzhou 350025, China.; School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.; School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.; 900th Hospital of PLA Joint Logistic Support Force, Fuzhou 350025, China.; School of Pharmacy, Fujian University of Chinese Traditional Medicine, Fuzhou 350122, China.; 900th Hospital of PLA Joint Logistic Support Force, Fuzhou 350025, China.; School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.",False
40733767,Theragnostic applications of cyclodextrin-enhanced photothermal therapy in cancer management.,Carbohydrate polymers,2025,Jaya Lakkakula; Geetanjali Mallick; Chinmay Das; Imran Uddin,"Amity Institute of Biotechnology, Amity University Maharashtra, Mumbai-Pune Expressway, Bhatan, Panel, Mumbai, Maharashtra 410206, India; Centre for Computational Biology and Translational Research, Amity University Maharashtra, Mumbai-Pune Expressway, Bhatan, Panel, Mumbai, Maharashtra 410206, India. Electronic address: jrlakkakula@mum.amity.edu.; Amity Institute of Biotechnology, Amity University Maharashtra, Mumbai-Pune Expressway, Bhatan, Panel, Mumbai, Maharashtra 410206, India.; Amity Institute of Biotechnology, Amity University Maharashtra, Mumbai-Pune Expressway, Bhatan, Panel, Mumbai, Maharashtra 410206, India.; Department of Conservative Dentistry and Endodontics, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 600077, Tamil Nadu, India. Electronic address: usmani.imran@gmail.com.",False
40733128,Synthesis and Evaluation of [18F]AlF-NOTA-iPD-L1 as a Potential Theranostic Pair for [177Lu]Lu-DOTA-iPD-L1.,Pharmaceutics,2025,Guillermina Ferro-Flores; Myrna Luna-Gutiérrez; Blanca Ocampo-García; Nallely Jiménez-Mancilla; Nancy Lara-Almazán; Rigoberto Oros-Pantoja; Clara Santos-Cuevas; Erika Azorín-Vega; Laura Meléndez-Alafort,"Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares (ININ), Ocoyoacac 52750, Mexico.; Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares (ININ), Ocoyoacac 52750, Mexico.; Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares (ININ), Ocoyoacac 52750, Mexico.; Investigadora por México SECIHTI, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac 52750, Mexico.; Department of Nuclear Forensics and Analytical Chemistry, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac 52750, Mexico.; Faculty of Medicine, Universidad Autónoma del Estado de México, Toluca 50180, Mexico.; Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares (ININ), Ocoyoacac 52750, Mexico.; Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares (ININ), Ocoyoacac 52750, Mexico.; Immunology and Molecular Oncology Diagnostics Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy.",False
40733107,Overview of Preclinical and Clinical Trials of Nanoparticles for the Treatment of Brain Metastases.,Pharmaceutics,2025,Muhammad Izhar; Mohamed Al Gharyani; Ahed H Kattaa; Juan J Cardona; Ruchit P Jain; Elaheh Shaghaghian; Yusuke S Hori; Fred C Lam; Deyaaldeen Abu Reesh; Sara C Emrich; Louisa Ustrzynski; Armine Tayag; Maciej S Lesniak; Steven D Chang; David J Park,"Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.; Department of Neurological Surgery, Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.",False
40730899,Mammary intraepithelial lymphocytes and intestinal inputs shape T cell dynamics in lactogenesis.,Nature immunology,2025,Abigail Jaquish; Eleni Phung; Xutong Gong; Pilar Baldominos; Silvia Galván-Peña; Ian Magill; Isabelle Bursulaya; Eleonora Marina; Kerri Bertrand; Christina Chambers; Andrés R Muñoz-Rojas; Judith Agudo; Diane Mathis; Christophe Benoist; Deepshika Ramanan,"NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA, USA.; Biological Sciences Graduate Program, University of California, San Diego, La Jolla, CA, USA.; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA, USA.; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Immunology, Harvard Medical School, Boston, MA, USA.; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA.; Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA.; Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY, USA.; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA.; Parker Institute for Cancer Immunotherapy at Dana-Farber Cancer Institute, Boston, MA, USA.; New York Stem Cell Foundation, New York, NY, USA.; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Immunology, Harvard Medical School, Boston, MA, USA.; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA, USA. dramanan@salk.edu.; Department of Immunology, Harvard Medical School, Boston, MA, USA. dramanan@salk.edu.",False
40729737,Developing a Personalized Cancer Nanovaccine Using Coxsackievirus-Reprogrammed Cancer Cell Membranes for Enhanced Anti-Tumor Immunity.,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",2025,Amirhossein Bahreyni; Yasir Mohamud; Amrit Singh; Razieh Sadat Banijamali; Jeffrey Tang; Jingchun Zhang; Honglin Luo,"Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, V6Z 1Y6, Canada.; Department of Pathology and Laboratory of Medicine, University of British Columbia, Vancouver, BC, V6Z 1Y6, Canada.; Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, V6Z 1Y6, Canada.; Department of Pathology and Laboratory of Medicine, University of British Columbia, Vancouver, BC, V6Z 1Y6, Canada.; Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, V6Z 1Y6, Canada.; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, V6Z 1Y6, Canada.; Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, V6Z 1Y6, Canada.; Department of Pathology and Laboratory of Medicine, University of British Columbia, Vancouver, BC, V6Z 1Y6, Canada.; Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, V6Z 1Y6, Canada.; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, V6Z 1Y6, Canada.; Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, V6Z 1Y6, Canada.; Department of Pathology and Laboratory of Medicine, University of British Columbia, Vancouver, BC, V6Z 1Y6, Canada.; Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, V6Z 1Y6, Canada.; Department of Pathology and Laboratory of Medicine, University of British Columbia, Vancouver, BC, V6Z 1Y6, Canada.",False
40729049,Advances in Molecular Diagnostics and Targeted Therapeutic Approaches in HER-2 Positive Breast Cancer.,Asian Pacific journal of cancer prevention : APJCP,2025,Basma Albanyahyati; Hicham El Hadi; Youssef Bakri; Mehdi Karkouri; Abdeladim Moumen,"Diagnostic kit and medical devices center, Moroccan Foundation for Advanced Science Innovation and Research (MASCIR), University Mohammed VI Polytechnic, Lot 660, Hay Moulay Rachid Ben Guerir, 43150, Morocco.; Laboratory of Human Pathologies Biology, Department of Biology, Faculty of Sciences, University Mohammed V, Rabat, Morocco.; Genomic Center of Human Pathologies, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco.; Diagnostic kit and medical devices center, Moroccan Foundation for Advanced Science Innovation and Research (MASCIR), University Mohammed VI Polytechnic, Lot 660, Hay Moulay Rachid Ben Guerir, 43150, Morocco.; Laboratory of Human Pathologies Biology, Department of Biology, Faculty of Sciences, University Mohammed V, Rabat, Morocco.; Genomic Center of Human Pathologies, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco.; Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Morocco.; Pathology Department, Centre Hospitalier et Universitaire Ibn Rochd, Casablanca, Morocco.; Diagnostic kit and medical devices center, Moroccan Foundation for Advanced Science Innovation and Research (MASCIR), University Mohammed VI Polytechnic, Lot 660, Hay Moulay Rachid Ben Guerir, 43150, Morocco.",False
40729006,Serum Levels of IL-21 and IL-22 in Breast Cancer Patients-A Preliminary Study.,Current issues in molecular biology,2025,Jacek Kabut; Aleksandra Mielczarek-Palacz; Joanna Magdalena Gola; Elżbieta Chełmecka; Anita Gorzelak-Magiera; Patrycja Królewska-Daszczyńska; Sebastian Stępień; Jakub Szymon Wnuk; Iwona Gisterek-Grocholska,"Department of Oncology and Radiotherapy, Medical University of Silesia, 40-055 Katowice, Poland.; Department of Immunology and Serology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 40-055 Katowice, Poland.; Department of Molecular Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 40-055 Katowice, Poland.; Department of Medical Statistics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 40-055 Katowice, Poland.; Department of Oncology and Radiotherapy, Medical University of Silesia, 40-055 Katowice, Poland.; Department of Immunology and Serology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 40-055 Katowice, Poland.; Department of Immunology and Serology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 40-055 Katowice, Poland.; Department of Oncology and Radiotherapy, Medical University of Silesia, 40-055 Katowice, Poland.; Department of Oncology and Radiotherapy, Medical University of Silesia, 40-055 Katowice, Poland.",False
40728183,Effect and mechanism of local radiotherapy combined with immune checkpoint inhibitor in the treatment of metastatic triple negative breast cancer.,African journal of reproductive health,2025,Qiong Lu; Fei Wang; Lei Yu; Ping Lv,"Shanghai Concord Medical Cancer Center,Shanghai, China.; Shanghai Concord Medical Cancer Center,Shanghai, China.; Shanghai Concord Medical Cancer Center,Shanghai, China.; Shanghai Concord Medical Cancer Center,Shanghai, China.",False
40727978,Dynamic Changes in Breast Cancer Receptor Status: A Case Report Highlighting the Importance of Repeat Biopsies in Guiding Treatment Strategies.,Journal of investigative medicine high impact case reports,2025,Navkirat Kahlon; Sujatha Baddam; Nahush Bansal; Zaheer Qureshi; Jhansi Maradana,"Mass General Cancer Center at Wentworth-Douglass Hospital, Dover, NH, USA.; Internal Medicine, Huntsville Hospital, AL, USA.; Internal Medicine,University of Toledo Medical Center, OH, USA.; The Frank H. Netter M.D. School of Medicine, Quinnipiac University, Bridgeport, CT, USA.; Mass General Cancer Center at Wentworth-Douglass Hospital, Dover, NH, USA.",False
40727760,APG-115 Induces SLC7A11-Mediated Ferroptosis and Upregulates PD-L1 Expression in Thyroid Cancer.,ACS omega,2025,Lei Liang; Zhulan Chen; Defeng Lei; Chunwei Mo; Deren Lan; Juanru Ke; Weiqi Wang; Zhuo Yang; Xin Guo; Dong Chen; Yongsheng Zhao; Haibo Chen,"Department of Nuclear Medicine, Peking University Shenzhen Hospital, 1120 Lianhua Road, Shenzhen 518036, Guangdong, China.; Department of Nuclear Medicine, Peking University Shenzhen Hospital, 1120 Lianhua Road, Shenzhen 518036, Guangdong, China.; Shantou University Medical College, Shantou 515041, Guangdong, China.; Department of Nuclear Medicine, Peking University Shenzhen Hospital, 1120 Lianhua Road, Shenzhen 518036, Guangdong, China.; Department of Nuclear Medicine, Peking University Shenzhen Hospital, 1120 Lianhua Road, Shenzhen 518036, Guangdong, China.; Department of Nuclear Medicine, Peking University Shenzhen Hospital, 1120 Lianhua Road, Shenzhen 518036, Guangdong, China.; Department of Nuclear Medicine, Peking University Shenzhen Hospital, 1120 Lianhua Road, Shenzhen 518036, Guangdong, China.; Department of Nuclear Medicine, Peking University Shenzhen Hospital, 1120 Lianhua Road, Shenzhen 518036, Guangdong, China.; Department of Nuclear Medicine, Peking University Shenzhen Hospital, 1120 Lianhua Road, Shenzhen 518036, Guangdong, China.; Department of Central Laboratory, Peking University Shenzhen Hospital, 1120 Lianhua Road, Shenzhen 518036, Guangdong, China.; Department of Thyroid and Breast Surgery, Peking University Shenzhen Hospital, 1120 Lianhua Road, Shenzhen 518036, Guangdong, China.; Department of Nuclear Medicine, Peking University Shenzhen Hospital, 1120 Lianhua Road, Shenzhen 518036, Guangdong, China.; Department of Nuclear Medicine, Peking University Shenzhen Hospital, 1120 Lianhua Road, Shenzhen 518036, Guangdong, China.",False
40727077,FMRP silencing via siRNA lipid nanoparticles to reprogram the tumor microenvironment and enhance anti-PD-1 efficacy in triple-negative breast cancer.,Materials today. Bio,2025,Letian Bai; Xinyan Hao; Wenjie Xu; Hai Huang; Mengen Guo; Yanwen Zhang; Daxiong Xiang; Guoping Yang; Junyong Wu; Chuanpin Chen,"Department of Pharmacy, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, China.; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.; Institute of Clinical Pharmacy, Central South University, Changsha, 410011, China.; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.; Institute of Clinical Pharmacy, Central South University, Changsha, 410011, China.; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.; Institute of Clinical Pharmacy, Central South University, Changsha, 410011, China.; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.; Institute of Clinical Pharmacy, Central South University, Changsha, 410011, China.; Department of Pharmacy, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, China.; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.; Institute of Clinical Pharmacy, Central South University, Changsha, 410011, China.; Center of Clinical Pharmacology, the Third Xiangya Hospital, Central South University, Changsha, 410003, China.; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.; Institute of Clinical Pharmacy, Central South University, Changsha, 410011, China.; Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.; Department of Pharmacy, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, China.",False
40725937,Prognostic and immunological significance of CD82 in cancers with focus on hepatocellular carcinoma: A bioinformatics approach.,Medicine,2025,Sikandar Ali; Shiyu Liu; Jiali Chen; Jawad Ullah; Guoyu Mou; Xiaohua Huang,"Department of Clinical Biochemistry, College of Laboratory Medicine, Dalian Medical University, Dalian, China.; Department of Clinical Biochemistry, College of Laboratory Medicine, Dalian Medical University, Dalian, China.; Department of Clinical Biochemistry, College of Laboratory Medicine, Dalian Medical University, Dalian, China.; Department of Clinical Biochemistry, College of Laboratory Medicine, Dalian Medical University, Dalian, China.; Department of Breast Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.; Department of Clinical Biochemistry, College of Laboratory Medicine, Dalian Medical University, Dalian, China.",False
40725123,PD-1/PD-L1 Inhibitors and Chemotherapy Synergy: Impact on Drug Resistance and PD-L1 Expression in Breast Cancer-Immune Cell Co-Cultures.,International journal of molecular sciences,2025,Güneş Özen Eroğlu; Ayşe Erol Bozkurt; İlhan Yaylım; Dürdane Serap Kuruca,"Department of Molecular Medicine, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul 34093, Turkey.; Institute of Graduate Studies in Health Science, Istanbul University, Istanbul 34126, Turkey.; Department of Medical Biology, Faculty of Medicine, Istanbul University, Istanbul 34390, Turkey.; Department of Molecular Medicine, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul 34093, Turkey.; Department of Physiology, Faculty of Medicine, Istanbul Atlas University, Istanbul 34408, Turkey.",False
40723292,Integration of Single-Cell Analysis and Bulk RNA Sequencing Data Using Multi-Level Attention Graph Neural Network for Precise Prognostic Stratification in Thyroid Cancer.,Cancers,2025,Langping Tan; Zhenjun Huang; Yongjian Chen; Zehua Wang; Zijia Lai; Xinzhi Peng; Cheng Zhang; Ruichong Lin; Wenhao Ouyang; Yunfang Yu; Miaoyun Long,"Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Thyroid Surgery, Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Thyroid Surgery, Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.; Dermatology and Venereology Division, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.; UMedEVO and UMedREVO Artificial Intelligence Technology (Guangzhou) Co., Ltd., Guangzhou 510275, China.; UMedEVO and UMedREVO Artificial Intelligence Technology (Guangzhou) Co., Ltd., Guangzhou 510275, China.; Faculty of Innovation Engineering, Macau University of Science and Technology, Taipa, Macao, China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Thyroid Surgery, Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Thyroid Surgery, Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Thyroid Surgery, Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.; Faculty of Innovation Engineering, Macau University of Science and Technology, Taipa, Macao, China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Thyroid Surgery, Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Thyroid Surgery, Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.; Guangdong Provincial Key Laboratory of Cancer Pathogenesis and Precision Diagnosis and Treatment, AI Big Data Laboratory, Shenshan Medical Center, Memorial Hospital of Sun Yat-sen University, Shanwei 516600, China.; Institute for AI in Medicine and Faculty of Medicine, Macau University of Science and Technology, Taipa, Macao, China.; Department of Breast Surgery, The First Affiliated Hospital, Jinan University, Guangzhou 510632, China.; Department of Thyroid Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangzhou 510655, China.",True
40723191,Toxicity Profiles of Antibody-Drug Conjugates: Synthesis and Graphical Insights to Optimize Patient-Centered Treatment Strategies for HER2-Negative Metastatic Breast Cancer.,Cancers,2025,Bérénice Collineau; Anthony Gonçalves; Marie Domon; Damien Bruyat; François Bertucci; Alexandre de Nonneville,"Institut Paoli-Calmettes, Department of Medical Oncology, 13009 Marseille, France.; Institut Paoli-Calmettes, Department of Medical Oncology, 13009 Marseille, France.; Institut Paoli-Calmettes, CRCM (Centre de Recherche en Cancérologie de Marseille), Aix-Marseille University, 13009 Marseille, France.; Institut Paoli-Calmettes, INSERM (Institut National de la Santé et de la Recherche Médicale), Aix-Marseille University, 13009 Marseille, France.; Institut Paoli-Calmettes, Department of Palliative and Supportive Care, 13009 Marseille, France.; Institut Paoli-Calmettes, Department of Medical Oncology, 13009 Marseille, France.; Institut Paoli-Calmettes, Department of Medical Oncology, 13009 Marseille, France.; Institut Paoli-Calmettes, CRCM (Centre de Recherche en Cancérologie de Marseille), Aix-Marseille University, 13009 Marseille, France.; Institut Paoli-Calmettes, INSERM (Institut National de la Santé et de la Recherche Médicale), Aix-Marseille University, 13009 Marseille, France.; Institut Paoli-Calmettes, Department of Medical Oncology, 13009 Marseille, France.; Institut Paoli-Calmettes, CRCM (Centre de Recherche en Cancérologie de Marseille), Aix-Marseille University, 13009 Marseille, France.; Institut Paoli-Calmettes, INSERM (Institut National de la Santé et de la Recherche Médicale), Aix-Marseille University, 13009 Marseille, France.",False
40722155,"Targeting cancer stem cells with CAR-based immunotherapy: biology, evidence, and future directions.",Cancer cell international,2025,Kaveh Hadiloo; Parsa Mostanadi; Ali Asadzadeh; Siavash Taremi; Abdolreza Esmaeilzadeh,"Department of Surgery, Velayat Clinical Research Development Unit, Qazvin University of Medical Sciences, Qazvin, Iran.; Student Research Committee, Department of Immunology, Zanjan University of Medical Science, Zanjan, Iran.; Student Research Committee, Department of Immunology, Zanjan University of Medical Science, Zanjan, Iran.; School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.; Student Research Committee, Department of Immunology, Zanjan University of Medical Science, Zanjan, Iran.; School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.; Student Research Committee, Department of Immunology, Zanjan University of Medical Science, Zanjan, Iran.; School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.; Profound Future Focused Innovative Cell and Gene Therapy, Pficell R&D Canadian Institution & Corporation, Ontario, Canada. a46reza@zums.ac.ir.; Cancer Gene Therapy Research Center (CGRC), Zanjan University of Medical Sciences, Zanjan, Iran. a46reza@zums.ac.ir.",True
40721545,Decoding tumor-infiltrating lymphocytes heterogeneity in ductal carcinoma in situ: immune microenvironment dynamics and prognostic insights.,Discover oncology,2025,Lingzi Wang; Yalong Yang; Yuhang Song; Jiahui Zeng; Hongmei Zheng; Xinhong Wu,"Breast Cancer Center, Tongji Medical College, Hubei Provincial Clinical Research Center for Breast Cancer, Hubei Cancer Hospital, Huazhong University of Science and Technology, National Key Clinical Specialty Construction Discipline, Wuhan Clinical Research Center for Breast Cancer, No.116 Zhuo Daoquan South Road, Wuhan, 430079, Hubei, China.; Breast Cancer Center, Tongji Medical College, Hubei Provincial Clinical Research Center for Breast Cancer, Hubei Cancer Hospital, Huazhong University of Science and Technology, National Key Clinical Specialty Construction Discipline, Wuhan Clinical Research Center for Breast Cancer, No.116 Zhuo Daoquan South Road, Wuhan, 430079, Hubei, China.; Breast Cancer Center, Tongji Medical College, Hubei Provincial Clinical Research Center for Breast Cancer, Hubei Cancer Hospital, Huazhong University of Science and Technology, National Key Clinical Specialty Construction Discipline, Wuhan Clinical Research Center for Breast Cancer, No.116 Zhuo Daoquan South Road, Wuhan, 430079, Hubei, China.; Breast Cancer Center, Tongji Medical College, Hubei Provincial Clinical Research Center for Breast Cancer, Hubei Cancer Hospital, Huazhong University of Science and Technology, National Key Clinical Specialty Construction Discipline, Wuhan Clinical Research Center for Breast Cancer, No.116 Zhuo Daoquan South Road, Wuhan, 430079, Hubei, China.; Breast Cancer Center, Tongji Medical College, Hubei Provincial Clinical Research Center for Breast Cancer, Hubei Cancer Hospital, Huazhong University of Science and Technology, National Key Clinical Specialty Construction Discipline, Wuhan Clinical Research Center for Breast Cancer, No.116 Zhuo Daoquan South Road, Wuhan, 430079, Hubei, China. zhenghongmeicj@163.com.; Breast Cancer Center, Tongji Medical College, Hubei Provincial Clinical Research Center for Breast Cancer, Hubei Cancer Hospital, Huazhong University of Science and Technology, National Key Clinical Specialty Construction Discipline, Wuhan Clinical Research Center for Breast Cancer, No.116 Zhuo Daoquan South Road, Wuhan, 430079, Hubei, China. wuxinhong_9@sina.com.",False
40716359,Biomarkers of response and resistance to immune checkpoint inhibitors in breast cancer.,"Breast (Edinburgh, Scotland)",2025,Michelle Li; François Panet; Vittoria Barberi; Roberto Salgado; Mafalda Oliveira; Sherene Loi,"Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; CISSS de la Montérégie-Centre, Département de Médecine, Service d'hémato-oncologie, Longueuil, Québec, Canada.; Sapienza University of Rome, Department of Radiological, Oncological and Pathological Science, Italy; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Pathology, ZAS Hospitals, Antwerp, Belgium; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Medical Oncology Department, Vall d'Hebron Hospital, Barcelona, Spain. Electronic address: moliveira@vhio.net.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Electronic address: Sherene.Loi@petermac.org.",False
40715915,"Bridging molecular insights and clinical application: non-coding RNAs, targeted drug delivery, and metastatic breast cancer therapy.",Discover oncology,2025,Sohini Chakraborty; Satarupa Banerjee,"Department of Biotechnology, School of Applied Sciences, Reva University, Bengaluru, 560064, Karnataka, India.; Department of Biotechnology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India.; Department of Biotechnology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India. satarupa.banerjee@vit.ac.in.",False
40720172,Self-Assembling Peptides Alter Cell Death Pathway for Pyroptosis-Enhanced Immune Activation.,Journal of medicinal chemistry,2025,Hongxia Zhang; Weiyu Xing; Yang Zhang; Jiaxin Zhou; Yulu Wang; Gongyu Li; Zhen Zheng,"The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China.; The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China.; The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China.; Tianjin Key Laboratory of Biosensing and Molecular Recognition, Research Center for Analytical Science, Frontiers Science Center for New Organic Matter, College of Chemistry, Nankai University, Tianjin 300071, China.; The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China.; Tianjin Key Laboratory of Biosensing and Molecular Recognition, Research Center for Analytical Science, Frontiers Science Center for New Organic Matter, College of Chemistry, Nankai University, Tianjin 300071, China.; The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China.",False
40718602,Acute Liver Failure and Hepatic Encephalopathy Secondary to Extensive Liver Metastases from Breast Cancer Successfully Treated Using Dose Modified Weekly Nab-paclitaxel and Trastuzumab.,Euroasian journal of hepato-gastroenterology,2025,Ajay Gupta,"Department of Medical Oncology, Indraprastha Apollo Hospital, Institute of Liver and Biliary Sciences, New Delhi, India.",False
40718485,Multiplex imaging analysis of the tumor immune microenvironment for guiding precision immunotherapy.,Frontiers in immunology,2025,Feng Liu; Guiqing Li; Yi Zheng; Yanxia Liu; Kang Liu,"Faculty of Medical Images, Shandong Second Medical University, Weifang, Shandong, China.; Department of Oncology, Afiliated Hospital of Shandong Second Medical University, Weifang, Shandong, China.; Shandong Provincial Key Medical and Health Discipline of Affiliated Hospital of Shandong Second Medical University in Oncology, Weifang, Shandong, China.; Department of Oncology, Afiliated Hospital of Shandong Second Medical University, Weifang, Shandong, China.; Shandong Provincial Key Medical and Health Discipline of Affiliated Hospital of Shandong Second Medical University in Oncology, Weifang, Shandong, China.; Department of Oncology, Afiliated Hospital of Shandong Second Medical University, Weifang, Shandong, China.; Shandong Provincial Key Medical and Health Discipline of Affiliated Hospital of Shandong Second Medical University in Oncology, Weifang, Shandong, China.; Department of Oncology, Afiliated Hospital of Shandong Second Medical University, Weifang, Shandong, China.; Shandong Provincial Key Medical and Health Discipline of Affiliated Hospital of Shandong Second Medical University in Oncology, Weifang, Shandong, China.; Department of Oncology, Afiliated Hospital of Shandong Second Medical University, Weifang, Shandong, China.; Shandong Provincial Key Medical and Health Discipline of Affiliated Hospital of Shandong Second Medical University in Oncology, Weifang, Shandong, China.",False
40717985,Mechanism and application of copper-based nanomedicines in activating tumor immunity through oxidative stress modulation.,Frontiers in pharmacology,2025,Cong Xia; Zirun Luo; Zhen Feng; Qianshi Zhang; Chenglai Xia,"Department of Gastrointestinal Surgery, The Second Hospital of Dalian Medical University, Dalian, China.; Department of Breast, Thyroid and Head-Neck Surgery, The Third Xiangya Hospital of Central South University, Changsha, China.; Department of Gastrointestinal Surgery, The Second Hospital of Dalian Medical University, Dalian, China.; Department of Gastrointestinal Surgery, The Second Hospital of Dalian Medical University, Dalian, China.; Scientific Research Center, Foshan Women and Children Hospital Affiliated with Guangdong Medical University, Foshan, China.",False
40717879,Predictive Biomarkers in Cancer Immunotherapy: A Narrative Review Across Selected Solid Tumors.,Cureus,2025,Mehak Puntambekar; Neville Shery; Ishaan Parokkaran; Mohammed Al-Hamas,"Medicine and Surgery, Pilgrim Hospital, United Lincolnshire Hospitals National Health Service (NHS) Trust, Boston, GBR.; General Medicine, Pilgrim Hospital, United Lincolnshire Hospitals National Health Service (NHS) Trust, Boston, GBR.; Emergency Medicine, Pilgrim Hospital, United Lincolnshire Hospitals National Health Service (NHS) Trust, Boston, GBR.; Acute Internal Medicine, University of Hull, Hull, GBR.",False
40715739,First unscheduled hospitalization in advanced cancer as a prognostic indicator of poor survival and trigger for palliative care referral.,Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico,2025,Alberto Alonso-Babarro; Juan Luis Torres-Tenor; Andrea García-Leal; Darío Sánchez-Cabrero; Lorena Ostios-García; Jesús Miranda-Poma; Laura Gutiérrez-Sainz; Julia Villamayor-Sánchez; José Abelardo Blanco-Iglesias; Javier Mateo-Flores; Adriana Vañó; Eduardo Bruera,"Department of Palliative Care, La Paz Hospital, Paseo de la Castellana 261, 28046, Madrid, Spain.; Department of Palliative Care, La Paz Hospital, Paseo de la Castellana 261, 28046, Madrid, Spain. torrestenor@yahoo.es.; Department of Medical Oncology, La Paz Hospital, Madrid, Spain.; Department of Medical Oncology, La Paz Hospital, Madrid, Spain.; Department of Medical Oncology, La Paz Hospital, Madrid, Spain.; Department of Medical Oncology, QuironSalud Madrid Hospital, Pozuelo de Alarcón, Spain.; Department of Medical Oncology, La Paz Hospital, Madrid, Spain.; Department of Medical Oncology, La Paz Hospital, Madrid, Spain.; Department of Emergency Medicine, Comarcal Monforte de Lemos Hospital, Monforte de Lemos, Spain.; Department of Palliative Care, Clínico San Carlos Hospital, Madrid, Spain.; Department of Palliative Care, MD Anderson Cancer Center Madrid, Madrid, Spain.; Department of Palliative Care and Rehabilitation Medicine, The University of Texas MD Anderson Cancer, Houston, TX, USA.",False
40715365,A lipid metabolism-related gene signature for risk stratification and prognosis prediction in patients with breast cancer.,Scientific reports,2025,Wuqian Mai; Yayi Jiao; Tuo Deng,"National Clinical Research Center for Metabolic Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China.; Key Laboratory of Diabetes Immunology, Ministry of Education, and Metabolic Syndrome Research Center, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China.; National Clinical Research Center for Metabolic Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China.; Key Laboratory of Diabetes Immunology, Ministry of Education, and Metabolic Syndrome Research Center, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China.; National Clinical Research Center for Metabolic Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China. dengtuo@csu.edu.cn.; Key Laboratory of Diabetes Immunology, Ministry of Education, and Metabolic Syndrome Research Center, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China. dengtuo@csu.edu.cn.; Clinical Immunology Center, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China. dengtuo@csu.edu.cn.",False
40713639,Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies.,Journal of translational medicine,2025,Annamaria Salvati; Viola Melone; Alessandro Giordano; Jessica Lamberti; Domenico Palumbo; Luigi Palo; Dilia Rea; Domenico Memoli; Vittoria Simonis; Elena Alexandrova; Francesco Silvestro; Francesca Rizzo; Alessandro Weisz; Roberta Tarallo; Giovanni Nassa,"Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry ""Scuola Medica Salernitana"", University of Salerno, via S. Allende, 1, Baronissi, 84081, SA, Italy.; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry ""Scuola Medica Salernitana"", University of Salerno, via S. Allende, 1, Baronissi, 84081, SA, Italy.; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry ""Scuola Medica Salernitana"", University of Salerno, via S. Allende, 1, Baronissi, 84081, SA, Italy.; Genome Research Center for Health - CRGS, Baronissi, SA, 84081, Italy.; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry ""Scuola Medica Salernitana"", University of Salerno, via S. Allende, 1, Baronissi, 84081, SA, Italy.; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry ""Scuola Medica Salernitana"", University of Salerno, via S. Allende, 1, Baronissi, 84081, SA, Italy.; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry ""Scuola Medica Salernitana"", University of Salerno, via S. Allende, 1, Baronissi, 84081, SA, Italy.; Genome Research Center for Health - CRGS, Baronissi, SA, 84081, Italy.; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry ""Scuola Medica Salernitana"", University of Salerno, via S. Allende, 1, Baronissi, 84081, SA, Italy.; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry ""Scuola Medica Salernitana"", University of Salerno, via S. Allende, 1, Baronissi, 84081, SA, Italy.; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry ""Scuola Medica Salernitana"", University of Salerno, via S. Allende, 1, Baronissi, 84081, SA, Italy.; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry ""Scuola Medica Salernitana"", University of Salerno, via S. Allende, 1, Baronissi, 84081, SA, Italy.; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry ""Scuola Medica Salernitana"", University of Salerno, via S. Allende, 1, Baronissi, 84081, SA, Italy.; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry ""Scuola Medica Salernitana"", University of Salerno, via S. Allende, 1, Baronissi, 84081, SA, Italy.; Genome Research Center for Health - CRGS, Baronissi, SA, 84081, Italy.; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry ""Scuola Medica Salernitana"", University of Salerno, via S. Allende, 1, Baronissi, 84081, SA, Italy.; Genome Research Center for Health - CRGS, Baronissi, SA, 84081, Italy.; Molecular Pathology and Medical Genomics Unit, AOU ""S. Giovanni di Dio e Ruggi d'Aragona"", University of Salerno, Salerno, Italy.; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry ""Scuola Medica Salernitana"", University of Salerno, via S. Allende, 1, Baronissi, 84081, SA, Italy. rtarallo@unisa.it.; Genome Research Center for Health - CRGS, Baronissi, SA, 84081, Italy. rtarallo@unisa.it.; Molecular Pathology and Medical Genomics Unit, AOU ""S. Giovanni di Dio e Ruggi d'Aragona"", University of Salerno, Salerno, Italy. rtarallo@unisa.it.; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry ""Scuola Medica Salernitana"", University of Salerno, via S. Allende, 1, Baronissi, 84081, SA, Italy. gnassa@unisa.it.; Genome Research Center for Health - CRGS, Baronissi, SA, 84081, Italy. gnassa@unisa.it.; Molecular Pathology and Medical Genomics Unit, AOU ""S. Giovanni di Dio e Ruggi d'Aragona"", University of Salerno, Salerno, Italy. gnassa@unisa.it.",False
40713509,"FLNA, a disulfidptosis-related gene, modulates tumor immunity and progression in colorectal cancer.",Cellular & molecular biology letters,2025,Qiong Li; Renhong Huang; Lingling Lv; Haifeng Ying; Yuan Wu; YuQing Huang; Yuxi Li; Wen Ma; Xiaoshuang Liu; Qinghui Meng; Fengying Xing; Yan Shen; Lan Zheng,"Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200120, China. Liqiong427@163.com.; Department of Traditional Chinese Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China. Liqiong427@163.com.; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Department of Traditional Chinese Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.; Department of Traditional Chinese Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.; Department of Traditional Chinese Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.; Department of Traditional Chinese Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.; Department of Traditional Chinese Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.; Department of Acupuncture, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200120, China.; Department of General Surgery, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200120, China.; Beijing Research Institute of Science and Technology, Beijing Milu Ecological Research Center, Beijing, 100076, China. mengqinghui2006@163.com.; Experimental Animal Center, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200011, China. xingfengying@163.com.; State Key Laboratory of Medical Genomics, Research Center for Experimental Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China. sy40685@rjh.com.cn.; Department of Acupuncture, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200120, China. windy9453@126.com.",False
40712726,Controlled Delivery of C-C Motif Chemokine Ligand 25 by a Hydrogel for Tumor Microenvironment Remodeling in Triple Negative Breast Cancer.,Acta biomaterialia,2025,Meng Guan; Junfeng Ding; Ge Zhu; Kuirong Mao; Xiandi Meng; Xiuxiu Cong; Huizhu Tan; Yanbao Xin; Mengfei Zhao; Jiaxuan Li; Haorui Wang; Yue Lv; Huating Sun; Chaoliang He; Hongmei Chen; Yong-Guang Yang; Yanqiu Song; Yuning Zhang; Tianmeng Sun,"Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital of Jilin University, Changchun, Jilin, 130021, China; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, 130021, China; Cancer Center, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.; CAS Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, Jilin, P. R. China; School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, 230026, Anhui, P. R. China.; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital of Jilin University, Changchun, Jilin, 130021, China; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, 130021, China; Cancer Center, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital of Jilin University, Changchun, Jilin, 130021, China; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, 130021, China.; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital of Jilin University, Changchun, Jilin, 130021, China; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, 130021, China.; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital of Jilin University, Changchun, Jilin, 130021, China; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, 130021, China.; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital of Jilin University, Changchun, Jilin, 130021, China; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, 130021, China.; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital of Jilin University, Changchun, Jilin, 130021, China; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, 130021, China.; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital of Jilin University, Changchun, Jilin, 130021, China; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, 130021, China.; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital of Jilin University, Changchun, Jilin, 130021, China; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, 130021, China.; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital of Jilin University, Changchun, Jilin, 130021, China; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, 130021, China.; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital of Jilin University, Changchun, Jilin, 130021, China; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, 130021, China.; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital of Jilin University, Changchun, Jilin, 130021, China; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, 130021, China.; CAS Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, Jilin, P. R. China; School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, 230026, Anhui, P. R. China.; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250022, China.; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital of Jilin University, Changchun, Jilin, 130021, China; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, 130021, China; International Center of Future Science, Jilin University, Changchun, Jilin, 130021, China.; Cancer Center, The First Hospital of Jilin University, Changchun, Jilin, 130021, China. Electronic address: song_yq@jlu.edu.cn.; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital of Jilin University, Changchun, Jilin, 130021, China; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, 130021, China. Electronic address: zhangyuning@jlu.edu.cn.; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital of Jilin University, Changchun, Jilin, 130021, China; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, 130021, China; International Center of Future Science, Jilin University, Changchun, Jilin, 130021, China; State Key Laboratory of Supramolecular Structure and Materials, Jilin University, Changchun, Jilin, 130021, China. Electronic address: tsun41@jlu.edu.cn.",False
40712694,Breaking Immune Evasion in Breast Cancer by Targeting COX-2/PGE2 Pathway.,Molecular and cellular endocrinology,2025,Xuewei Zheng; Junxiang Wang; Yanan OuYang; Kaiyuan Yao; Jiayu Zheng; Li Zeng; Jingjing Wang; Hetao Chen; Haoming Du; Dongliao Fu; Linlin Shi; Anshun Zhao; Qinan Yin,"Precision Medicine Laboratory, School of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471003, China.; Precision Medicine Laboratory, School of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471003, China.; Department of Urology, Xi'an People's Hospital (Xi'an Fourth Hospital), School of Life Sciences and Medicine, Northwest University, Xi'an, 710199, China.; Henan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment, Henan Key Laboratory of Cancer Epigenetics, College of Basic Medicine and Forensic Medicine, Cancer Hospital, The First Affiliated Hospital (College of Clinical Medicine) of Henan University of Science and Technology, Luoyang 471003, China.; Precision Medicine Laboratory, School of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471003, China.; Precision Medicine Laboratory, School of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471003, China.; Precision Medicine Laboratory, School of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471003, China.; Department of Clinical Laboratory, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang 471003, China.; School of Medicine, Jinan University, Guangzhou 510632, China.; Precision Medicine Laboratory, School of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471003, China.; Henan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment, Henan Key Laboratory of Cancer Epigenetics, College of Basic Medicine and Forensic Medicine, Cancer Hospital, The First Affiliated Hospital (College of Clinical Medicine) of Henan University of Science and Technology, Luoyang 471003, China.; Department of Clinical Laboratory, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang 471003, China. Electronic address: anshunzhao@haust.edu.cn.; Precision Medicine Laboratory, School of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471003, China. Electronic address: qinanyin@haust.edu.cn.",False
40711726,The network map of mucin 1 mediated signaling in cancer progression and immune modulation.,Discover oncology,2025,Akhina Palollathil; Shobha Dagamajalu; Mukhtar Ahmed; Manavalan Vijayakumar; Thottethodi Subrahmanya Keshava Prasad; Rajesh Raju,"Center for Systems Biology and Molecular Medicine [An ICMR-Collaborating Centre of Excellence 2024-2029], Yenepoya Research Centre, Yenepoya (Deemed to Be University), Mangalore, Karnataka, 575018, India.; Center for Systems Biology and Molecular Medicine [An ICMR-Collaborating Centre of Excellence 2024-2029], Yenepoya Research Centre, Yenepoya (Deemed to Be University), Mangalore, Karnataka, 575018, India.; Department of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Kingdom of Saudi Arabia.; Department of Surgical Oncology, Yenepoya Medical College, Yenepoya (Deemed to Be University), Mangalore, Karnataka, 575018, India. mvijai2013@gmail.com.; Center for Systems Biology and Molecular Medicine [An ICMR-Collaborating Centre of Excellence 2024-2029], Yenepoya Research Centre, Yenepoya (Deemed to Be University), Mangalore, Karnataka, 575018, India. keshav@yenepoya.edu.in.; Center for Systems Biology and Molecular Medicine [An ICMR-Collaborating Centre of Excellence 2024-2029], Yenepoya Research Centre, Yenepoya (Deemed to Be University), Mangalore, Karnataka, 575018, India. rajrrnbt@gmail.com.; Centre for Integrative Omics Data Science (CIODS), Yenepoya Research Centre, Yenepoya (Deemed to Be University), Mangalore, Karnataka, 575018, India. rajrrnbt@gmail.com.",False
40710292,The Activity of Human NK Cells Towards 3D Heterotypic Cellular Tumor Model of Breast Cancer.,Cells,2025,Anastasia Leonteva; Maria Abdurakhmanova; Maria Bogachek; Tatyana Belovezhets; Anna Yurina; Olga Troitskaya; Sergey Kulemzin; Vladimir Richter; Elena Kuligina; Anna Nushtaeva,"Scientific Center of Genetics and Life Sciences, Sirius University of Science and Technology, 1 Olimpiysky Avenue, Krasnodar Region, Sirius 354340, Russia.; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentiev Ave. 8, Novosibirsk 630090, Russia.; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentiev Ave. 8, Novosibirsk 630090, Russia.; Scientific Center of Genetics and Life Sciences, Sirius University of Science and Technology, 1 Olimpiysky Avenue, Krasnodar Region, Sirius 354340, Russia.; Institute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentiev Ave. 8/2, Novosibirsk 630090, Russia.; Institute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentiev Ave. 8/2, Novosibirsk 630090, Russia.; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentiev Ave. 8, Novosibirsk 630090, Russia.; Institute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentiev Ave. 8/2, Novosibirsk 630090, Russia.; Department of Natural Sciences, Novosibirsk State University, Pirogova Str. 2, Novosibirsk 630090, Russia.; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentiev Ave. 8, Novosibirsk 630090, Russia.; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentiev Ave. 8, Novosibirsk 630090, Russia.; Scientific Center of Genetics and Life Sciences, Sirius University of Science and Technology, 1 Olimpiysky Avenue, Krasnodar Region, Sirius 354340, Russia.; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentiev Ave. 8, Novosibirsk 630090, Russia.",False
40710212,Optimizing Adjuvant Care in Early Breast Cancer: Multidisciplinary Strategies and Innovative Models from Canadian Centers.,"Current oncology (Toronto, Ont.)",2025,Angela Chan; Nancy Nixon; Muna Al-Khaifi; Alain Bestavros; Christine Blyth; Winson Y Cheung; Caroline Hamm; Thomas Joly-Mischlich; Mita Manna; Tom McFarlane; Laura V Minard; Sarah Naujokaitis; Christine Peragine; Cindy Railton; Scott Edwards,"Faculty of Medicine, BC Cancer, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 2T8, Canada.; Odette Cancer Centre, Sunnybrook Health Science Centre, University of Toronto, Toronto, ON M4N 3M5, Canada.; Faculté de Médecine, Université de Montréal, Montreal, QC H3T 1J4, Canada.; Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB T2N 5G2, Canada.; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 2T8, Canada.; Department of Medical Oncology, Windsor Regional Hospital, Windsor, ON N8W 1L9, Canada.; Université de Sherbrooke Cancer Research Institute (IRCUS), Université de Sherbrooke, Sherbrooke, QC J1E 4K8, Canada.; Department of Medical Oncology, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.; School of Pharmacy, University of Waterloo, Kitchener, ON N2G 1C5, Canada.; Department of Pharmacy, Nova Scotia Health, QEII Health Sciences Centre, Halifax, NS B3H 2Y9, Canada.; London Health Sciences Centre, London, ON N6A 5W9, Canada.; Odette Cancer Centre, Sunnybrook Health Science Centre, University of Toronto, Toronto, ON M4N 3M5, Canada.; Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB T2N 5G2, Canada.; Faculty of Medicine and School of Pharmacy, Memorial University of Newfoundland, St John's, NL A1B 3V6, Canada.",False
40710197,Predictive Factors of Response to Neoadjuvant Chemotherapy (NACT) and Immune Checkpoint Inhibitors in Early-Stage Triple-Negative Breast Cancer Patients (TNBC).,"Current oncology (Toronto, Ont.)",2025,Khashayar Yazdanpanah Ardakani; Francesca Fulvia Pepe; Serena Capici; Thoma Dario Clementi; Marina Elena Cazzaniga,"School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.; Phase 1 Research Center, Fondazione IRCC San Gerardo dei Tintori, 20090 Monza, Italy.; Phase 1 Research Center, Fondazione IRCC San Gerardo dei Tintori, 20090 Monza, Italy.; School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.; School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.; Phase 1 Research Center, Fondazione IRCC San Gerardo dei Tintori, 20090 Monza, Italy.",False
40710184,Role of Circulating Tumor DNA in Adapting Immunotherapy Approaches in Breast Cancer.,"Current oncology (Toronto, Ont.)",2025,Sudhir Kumar; Rossanna C Pezo,"Division of Medical Oncology and Hematology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada.; Division of Medical Oncology and Hematology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada.",False
40709054,Peripheral TNF-α and CD8+/CD28+ T Lymphocytes as Alternatives for PD-L1 Prediction in Breast Cancer Tumor Microenvironment: Stratified by Neoadjuvant Therapy.,Breast cancer (Dove Medical Press),2025,Jiangping Wu; Xin Ou; Keyu Yuan; Feng Shi; Quan Zhou; Suzhen Lyu; Yanping Li; Yanjie Zhao; Yu Cao; Jianping Sun; Qingkun Song,"Center of Clinical Epidemiology and Biobank, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, People's Republic of China.; Center of Clinical Epidemiology and Biobank, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, People's Republic of China.; Department of Breast Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People's Republic of China.; Department of Pathology, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People's Republic of China.; Department of Pathology, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100021, People's Republic of China.; Department of Breast Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People's Republic of China.; Department of Breast Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People's Republic of China.; Department of Medical Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People's Republic of China.; Center of Clinical Epidemiology and Biobank, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, People's Republic of China.; Center of Clinical Epidemiology and Biobank, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, People's Republic of China.; Center of Clinical Epidemiology and Biobank, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, People's Republic of China.; Department of Clinical Epidemiology, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People's Republic of China.",False
40708008,Targeted degradation of sICOSL reverses cytotoxic T cells dysfunction.,Experimental hematology & oncology,2025,Zhenghao Wu; Peng Zheng; Ruobing Qi; Yunxiao Xiao; Zihan Xi; Lei Dai; Tao Chen; Qianheng Wang; Furong Zhang; Rong Wang; Zimei Tang; Xiangwang Zhao; Jie Tan; Jie Ming; Ping Lei; Chunping Liu; Tao Huang,"Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. wu_zhenghao@126.com.; Department of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. wu_zhenghao@126.com.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital Sun Yat-Sen University, Guangzhou, China. wu_zhenghao@126.com.; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Department of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Department of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital Sun Yat-Sen University, Guangzhou, China.; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Department of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. liucpwhxh@hust.edu.cn.; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. huangtaowh@163.com.",False
40707784,The USP1-WDR48 deubiquitinase complex functions as a molecular switch regulating tumor-associated macrophage activation and anti-tumor response.,Cell death and differentiation,2025,Dianwen Han; Lijuan Wang; Shan Jiang; Peng Su; Bing Chen; Wenjing Zhao; Tong Chen; Ning Zhang; Xiaolong Wang; Yiran Liang; Yaming Li; Chen Li; Xi Chen; Dan Luo; Qifeng Yang,"Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.; Biological Resource Center, Qilu Hospital of Shandong University, Jinan, China.; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.; Department of Pathology, Qilu Hospital of Shandong University, Jinan, China.; Biological Resource Center, Qilu Hospital of Shandong University, Jinan, China.; Biological Resource Center, Qilu Hospital of Shandong University, Jinan, China.; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.; Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China. qifengy_sdu@163.com.; Biological Resource Center, Qilu Hospital of Shandong University, Jinan, China. qifengy_sdu@163.com.; Research Institute of Breast Cancer, Shandong University, Jinan, China. qifengy_sdu@163.com.",False
40707559,Impact of the PD-1/PD-L1 inhibitor SCL-1 on MDA-MB231 tumor growth in a humanized MHC-double knockout NOG mouse model.,Scientific reports,2025,Tomoatsu Ikeya; Tadashi Ashizawa; Akari Kanematsu; Chie Maeda; Akira Iizuka; Kazue Yamashita; Haruo Miyata; Yasufumi Kikuchi; Kouji Maruyama; Mamoru Ito; Ken Yamaguchi; Yasuto Akiyama,"Immunotherapy Division, Shizuoka Cancer Center Research Institute, 1007 Shimonagakubo, Nagaizumi-Cho, Sunto-Gun, Shizuoka, 411-8777, Japan.; Immunotherapy Division, Shizuoka Cancer Center Research Institute, 1007 Shimonagakubo, Nagaizumi-Cho, Sunto-Gun, Shizuoka, 411-8777, Japan.; Experimental Animal Facility, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.; Immunotherapy Division, Shizuoka Cancer Center Research Institute, 1007 Shimonagakubo, Nagaizumi-Cho, Sunto-Gun, Shizuoka, 411-8777, Japan.; Immunotherapy Division, Shizuoka Cancer Center Research Institute, 1007 Shimonagakubo, Nagaizumi-Cho, Sunto-Gun, Shizuoka, 411-8777, Japan.; Immunotherapy Division, Shizuoka Cancer Center Research Institute, 1007 Shimonagakubo, Nagaizumi-Cho, Sunto-Gun, Shizuoka, 411-8777, Japan.; Immunotherapy Division, Shizuoka Cancer Center Research Institute, 1007 Shimonagakubo, Nagaizumi-Cho, Sunto-Gun, Shizuoka, 411-8777, Japan.; Immunotherapy Division, Shizuoka Cancer Center Research Institute, 1007 Shimonagakubo, Nagaizumi-Cho, Sunto-Gun, Shizuoka, 411-8777, Japan.; Experimental Animal Facility, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.; Central Institute for Experimental Medicine and Life Science, Kawasaki, Japan.; Office of the President Emeritus, Shizuoka Cancer Center, Shizuoka, Japan.; Immunotherapy Division, Shizuoka Cancer Center Research Institute, 1007 Shimonagakubo, Nagaizumi-Cho, Sunto-Gun, Shizuoka, 411-8777, Japan. y.akiyama@scchr.jp.",False
40707500,Subtype- and race-specific variations in the immune landscape of breast cancer: therapeutic implications.,NPJ breast cancer,2025,Amod Sharma; Sarabjeet Kour Sudan; Kunwar Somesh Vikramdeo; Mohammad Aslam Khan; Muhammad Tahir; James E Carter; Todd Kendall; Cindy Nelson; Ajay P Singh; Seema Singh,"Department of Cell and Molecular Biology, University of Mississippi Medical Center, Jackson, MS, USA.; Cancer Center and Research Institute, University of Mississippi Medical Center, Jackson, MS, USA.; Department of Cell and Molecular Biology, University of Mississippi Medical Center, Jackson, MS, USA.; Cancer Center and Research Institute, University of Mississippi Medical Center, Jackson, MS, USA.; Department of Cell and Molecular Biology, University of Mississippi Medical Center, Jackson, MS, USA.; Cancer Center and Research Institute, University of Mississippi Medical Center, Jackson, MS, USA.; Department of Pathology, University of South Alabama, Mobile, AL, USA.; Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA.; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Pathology, University of South Alabama, Mobile, AL, USA.; Department of Pathology, University of South Alabama, Mobile, AL, USA.; Department of Pathology, Providence Hospital, University of South Alabama, Mobile, AL, USA.; Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA.; Department of Cell and Molecular Biology, University of Mississippi Medical Center, Jackson, MS, USA.; Cancer Center and Research Institute, University of Mississippi Medical Center, Jackson, MS, USA.; Department of Cell and Molecular Biology, University of Mississippi Medical Center, Jackson, MS, USA. ssingh3@umc.edu.; Cancer Center and Research Institute, University of Mississippi Medical Center, Jackson, MS, USA. ssingh3@umc.edu.",False
40707495,The untapped potential of radiation and immunotherapy for hormone receptor-positive breast cancer.,NPJ breast cancer,2025,Matthew Fenton; Miki Yoneyama; Erik Wennerberg; Tom Lund; Andrew Tutt; Alan Melcher; Sandra Demaria; Navita Somaiah,"Division of Radiotherapy and Imaging, Institute of Cancer Research, London, UK.; Royal Marsden NHS Foundation Trust, London, UK.; Division of Radiotherapy and Imaging, Institute of Cancer Research, London, UK.; Division of Radiotherapy and Imaging, Institute of Cancer Research, London, UK.; Royal Marsden NHS Foundation Trust, London, UK.; Division of Cancer Biology, Institute of Cancer Research, London, UK.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; The Breast Cancer Now Research Unit, Guy's Hospital Cancer Centre, King's College London, London, UK.; Division of Radiotherapy and Imaging, Institute of Cancer Research, London, UK.; Institute of Cancer Research/Royal Marsden Hospital Centre for Immunotherapy of Cancer, London, UK.; Weill Cornell Medicine, New York, NY, USA.; Division of Radiotherapy and Imaging, Institute of Cancer Research, London, UK. navita.somaiah@icr.ac.uk.; Royal Marsden NHS Foundation Trust, London, UK. navita.somaiah@icr.ac.uk.",False
40706744,Inhibition of KAT6A enhances immunotherapy efficacy in colorectal cancer by activating interferon response.,Cancer letters,2025,Shuling Han; Zhuo Chen; Chang Hong; Tianjiao Dang; Futing Bai; Yuli Ruan; Rui Yang; Xuefan Yu; Yingjue Li; Bojun Wang; Yue Ma; Feihong Chen; Ruxin Xiong; Yanqiao Zhang; Chao Liu,"Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150081, China; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin 150081, China; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin 150081, China; Department of Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150081, China; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin 150081, China; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin 150081, China.; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150081, China; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin 150081, China; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin 150081, China.; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150081, China; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin 150081, China; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin 150081, China.; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150081, China; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin 150081, China; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin 150081, China.; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150081, China; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin 150081, China; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin 150081, China.; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150081, China; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin 150081, China; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin 150081, China.; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150081, China; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin 150081, China; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin 150081, China.; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150081, China; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin 150081, China; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin 150081, China.; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150081, China; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin 150081, China; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin 150081, China.; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150081, China; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin 150081, China; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin 150081, China.; Department of Psychiatry, Jining Medical University, Jining 272067, China.; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150081, China; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin 150081, China; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin 150081, China.; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150081, China; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin 150081, China; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin 150081, China; Key Laboratory of Preservation of Human Genetic Resources and Disease Control in China (Harbin Medical University), Ministry of Education, Harbin 150081, China.; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150081, China; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin 150081, China; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin 150081, China; Key Laboratory of Preservation of Human Genetic Resources and Disease Control in China (Harbin Medical University), Ministry of Education, Harbin 150081, China. Electronic address: liuchao@hrbmu.edu.cn.",False
40704883,In Situ Tumor Surface Modification with Antibody Fragments for Antigen-Independent Versatile Cancer Immunotherapy.,ACS nano,2025,Seonwoo Kang; Yeoul Kang; Yelim Lee; Jaehyun Park; Junseok Lee; Won Jong Kim,"Department of Chemistry, POSTECH-CATHOLIC Biomedical Engineering Institute, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea.; Department of Chemistry, POSTECH-CATHOLIC Biomedical Engineering Institute, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea.; Department of Chemistry, POSTECH-CATHOLIC Biomedical Engineering Institute, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea.; Department of Chemistry, POSTECH-CATHOLIC Biomedical Engineering Institute, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea.; Department of Chemistry, POSTECH-CATHOLIC Biomedical Engineering Institute, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea.; Department of Molecular and Medical Pharmacology, California NanoSystems Institute (CNSI), Crump Institute for Molecular Imaging, University of California (UCLA) Los Angeles, 570 Westwood Plaza, Los Angeles, California 90095, United States.; Department of Chemistry, POSTECH-CATHOLIC Biomedical Engineering Institute, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea.; OmniaMed Co, Ltd., Pohang 37673, Republic of Korea.",True
40703447,The ubiquitin code of RAS proteins: Decoding its role in cancer progression.,iScience,2025,Yedan Shi; Yong Shen; Xiuyuan Zhang; Ning Zhu; Yuwei Ding; Ying Yuan; Juan Wang,"Department of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.; Zhejiang Provincial Clinical Research Center for CANCER, Hangzhou, Zhejiang 310009, China.; Cancer Center of Zhejiang University, Hangzhou, Zhejiang 310009, China.; Department of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.; Zhejiang Provincial Clinical Research Center for CANCER, Hangzhou, Zhejiang 310009, China.; Department of Breast Surgery and Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.; Department of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.; Zhejiang Provincial Clinical Research Center for CANCER, Hangzhou, Zhejiang 310009, China.; Cancer Center of Zhejiang University, Hangzhou, Zhejiang 310009, China.; Department of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.; Zhejiang Provincial Clinical Research Center for CANCER, Hangzhou, Zhejiang 310009, China.; Cancer Center of Zhejiang University, Hangzhou, Zhejiang 310009, China.; Department of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.; Zhejiang Provincial Clinical Research Center for CANCER, Hangzhou, Zhejiang 310009, China.; Cancer Center of Zhejiang University, Hangzhou, Zhejiang 310009, China.; Department of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.; Zhejiang Provincial Clinical Research Center for CANCER, Hangzhou, Zhejiang 310009, China.; Cancer Center of Zhejiang University, Hangzhou, Zhejiang 310009, China.; Department of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.; Zhejiang Provincial Clinical Research Center for CANCER, Hangzhou, Zhejiang 310009, China.; Cancer Center of Zhejiang University, Hangzhou, Zhejiang 310009, China.",True
40702728,Amlodipine as an Immunomodulatory Agent in Cancer Therapy: Enhancing Dendritic Cell Activation in Combination with Tumor-associated Antigen.,Molecular therapy : the journal of the American Society of Gene Therapy,2025,Zhixuan Wang; Xinxuan Huang; Lifan Duan; Shujie Tian; Chenxi Shi; Yongbin Mou; Heng Dong; Yu Gao; Lixing Weng,"State Key Laboratory of Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, Nanjing 210023, China.; State Key Laboratory of Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, Nanjing 210023, China.; State Key Laboratory of Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, Nanjing 210023, China.; State Key Laboratory of Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, Nanjing 210023, China.; State Key Laboratory of Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, Nanjing 210023, China.; Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China.; Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China. Electronic address: dongheng90@smail.nju.edu.cn.; State Key Laboratory of Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, Nanjing 210023, China. Electronic address: iamygao@njupt.edu.cn.; State Key Laboratory of Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, Nanjing 210023, China. Electronic address: lxweng@njupt.edu.cn.",False
40702719,Gelatin Methacryloyl Xerogel Puncture Implants Loaded with Cu0.5Mn2.5O4 Nanoparticles Synergizes Cuproptosis and STING Activation for Enhanced Breast Cancer Immunotherapy.,ACS nano,2025,Yechun Jiang; Weinan Zhang; Litao Liu; Yayun Wu; Weiqi Li; Jun Liang; Hui Shen; Shu Fang; Xianyu Huang; Zhaoyou Chu; Lingling Xu; Haisheng Qian,"School of Pharmaceutical Sciences, Anhui Medical University, Hefei 230022, P. R. China.; School of Biomedical Engineering, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei 230032, P. R. China.; School of Biomedical Engineering, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei 230032, P. R. China.; Department of Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei 230032, P. R. China.; School of Biomedical Engineering, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei 230032, P. R. China.; School of Biomedical Engineering, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei 230032, P. R. China.; School of Biomedical Engineering, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei 230032, P. R. China.; School of Biomedical Engineering, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei 230032, P. R. China.; School of Biomedical Engineering, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei 230032, P. R. China.; Department of Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei 230032, P. R. China.; School of Biomedical Engineering, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei 230032, P. R. China.; School of Biomedical Engineering, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei 230032, P. R. China.; Anhui Engineering Research Center for Medical Micro-Nano Devices, Anhui Medical University, Hefei 230011, P. R. China.",False
40702362,Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages.,Nature cancer,2025,Giulia Petroni; Claudia Galassi; Kenneth H Gouin; Hsiang-Han Chen; Aitziber Buqué; Norma Bloy; Takahiro Yamazaki; Ai Sato; Manuel Beltrán-Visiedo; Ginevra Campia; Carlos Jiménez-Cortegana; Aagam Shah; Alexander Kirchmair; Chiara Massa; Claudia Wickenhauser; Carlos Eduardo de Andrea; Belén Navarro-Rubio; Irantzu Serrano-Mendioroz; Esther Navarro Manzano; Alexandra M Satty; Brady Rippon; Francesca Finotello; Zlatko Trajanoski; Xi Kathy Zhou; Joseph M Scandura; Elena García-Martínez; Francisco Ayala de la Peña; María Esperanza Rodríguez-Ruiz; Barbara Seliger; Víctor Sánchez-Margalet; Luis de la Cruz-Merino; Reva K Basho; Stephen L Shiao; Heather L McArthur; Silvia C Formenti; Simon R V Knott; Lorenzo Galluzzi,"Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Department of Computer Science and Information Engineering, National Taiwan Normal University, Taipei, Taiwan.; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.; Department of Medical Biochemistry, Molecular Biology and Immunology, Faculty of Medicine, Universidad de Sevilla, Sevilla, Spain.; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria.; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.; Institute of Pathology, University Hospital Halle, Halle, Germany.; Department of Anatomy, Physiology and Pathology, Clínica Universidad de Navarra, Pamplona, Spain.; Department of Radiation Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain.; Centro Regional de Hemodonación, Murcia, Spain.; Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.; Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria.; Department of Molecular Biology, University of Innsbruck, Innsbruck, Austria.; Digital Science Center (DiSC), University of Innsbruck, Innsbruck, Austria.; Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria.; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.; Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, Murcia, Spain.; Universidad Católica San Antonio de Murcia, Guadalupe, Spain.; Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.; Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, Murcia, Spain.; Universidad de Murcia, Murcia, Spain.; Department of Radiation Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain.; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.; Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.; Institute for Translational Immunology, Brandenburg Medical School Theodor Fontane, Brandenburg an der Havel, Germany.; Department of Medical Biochemistry, Molecular Biology and Immunology, Faculty of Medicine, Universidad de Sevilla, Sevilla, Spain.; Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla, Department of Clinical Oncology, Hospital Universitario de la Virgen Macarena, Sevilla, Spain.; Department of Medical Biochemistry, Molecular Biology and Immunology, Faculty of Medicine, Universidad de Sevilla, Sevilla, Spain.; Department of Clinical Oncology, Hospital Universitario de la Virgen Macarena, Sevilla, Spain.; Ellison Institute of Technology, Los Angeles, CA, USA.; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Department of Radiology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. deadoc80@gmail.com.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA. deadoc80@gmail.com.; Sandra and Edward Meyer Cancer Center, New York, NY, USA. deadoc80@gmail.com.; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA. formenti@med.cornell.edu.; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. simon.knott@cshs.org.; Sandra and Edward Meyer Cancer Center, New York, NY, USA. simon.knott@cshs.org.; Caryl and Israel Englander Institute for Precision Medicine, New York, NY, USA. simon.knott@cshs.org.; Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA. simon.knott@cshs.org.",False
40700964,Selenium exposure on breast cancer risk and progression: Comprehensive analysis identifies MSRB1 as a novel therapeutic target.,Ecotoxicology and environmental safety,2025,Jingsong Cheng; Diyuan Zhang; Ningxi Wang; Ziheng Zheng; Cong Zhang; Nanting Chen; Yuanyuan Wan; Xue Chen; Qingyao Yin; Xinyi Zhu; Yu Zhao; Liming Yi; Na Sun,"Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing 400038, China; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou 510275, China; The Second Clinical College, Chongqing Medical University, Chongqing 400016, China.; Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing 400038, China; Key Laboratory of Chongqing Health Commission for Minimally Invasive and Precise Diagnosis and Treatment of Breast Cancer, Chongqing 400016, China.; College of Basic Medicine, Chongqing Medical University, Chongqing 400016, China.; The Second Clinical College, Chongqing Medical University, Chongqing 400016, China.; Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing 400038, China; Key Laboratory of Chongqing Health Commission for Minimally Invasive and Precise Diagnosis and Treatment of Breast Cancer, Chongqing 400016, China.; The Second Clinical College, Chongqing Medical University, Chongqing 400016, China.; College of Basic Medicine, Chongqing Medical University, Chongqing 400016, China.; The Second Clinical College, Chongqing Medical University, Chongqing 400016, China.; The Second Clinical College, Chongqing Medical University, Chongqing 400016, China.; The Second Clinical College, Chongqing Medical University, Chongqing 400016, China.; Medical Laboratory, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, Shanghai 200438, China. Electronic address: a765767910@163.com.; Department of Human Anatomy, Hunan University of Medicine, Huaihua 418000, China. Electronic address: limingyi@hnmu.edu.cn.; Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing 400038, China; Key Laboratory of Chongqing Health Commission for Minimally Invasive and Precise Diagnosis and Treatment of Breast Cancer, Chongqing 400016, China. Electronic address: nasunbio@tmmu.edu.cn.",False
40699477,RNF213 governs divergent tumor-immune dynamics across human cancers: a prognostic biomarker for immunotherapy stratification.,Discover oncology,2025,Jinpeng Wen; Zhekuan Lv; Mojiao Lu; Chuanming Zheng; Changtian Yin,"Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, 310014, Zhejiang, China.; Breast and Thyroid Surgery Department, The Affiliated Dongguan Songshan Lake Central Hospital, Guangdong Medical University, Dongguan, 523326, Guangdong, China.; Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, 310014, Zhejiang, China.; Postgraduate training base Alliance of Wenzhou Medical University (Zhejiang Provincial People's Hospital), Wenzhou, 325000, Zhejiang, China.; Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, 310014, Zhejiang, China.; Postgraduate training base Alliance of Wenzhou Medical University (Zhejiang Provincial People's Hospital), Wenzhou, 325000, Zhejiang, China.; Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, 310014, Zhejiang, China. mingdoc@163.com.; Zhejiang Provincial Clinical Research Center for Head & Neck Cancer, Hangzhou, 310014, China. mingdoc@163.com.; Zhejiang Key Laboratory of Precision Medicine Research on Head & Neck Cancer, Hangzhou, 310014, China. mingdoc@163.com.; Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, 310014, Zhejiang, China. yin454593539@163.com.; Zhejiang Provincial Clinical Research Center for Head & Neck Cancer, Hangzhou, 310014, China. yin454593539@163.com.; Zhejiang Key Laboratory of Precision Medicine Research on Head & Neck Cancer, Hangzhou, 310014, China. yin454593539@163.com.",True
40698682,LINC-PINT: A Distinctive Long Non-Coding RNA Functioning as a Potential Suppressor in Tumorigenesis.,Current topics in medicinal chemistry,2025,Jiayi Li; Yining Pan; Songqiang Li; Cheng Chen; Chengfu Yuan,"Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, China.; College of Basic Medical Science, China Three Gorges University, Yichang 443002, China.; Third-grade Pharmacological Laboratory on Traditional Chinese Medicine State Administration of Traditional Chinese Medicine, China Three Gorges University, China.; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, China.; College of Basic Medical Science, China Three Gorges University, Yichang 443002, China.; Third-grade Pharmacological Laboratory on Traditional Chinese Medicine State Administration of Traditional Chinese Medicine, China Three Gorges University, China.; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, China.; College of Basic Medical Science, China Three Gorges University, Yichang 443002, China.; Third-grade Pharmacological Laboratory on Traditional Chinese Medicine State Administration of Traditional Chinese Medicine, China Three Gorges University, China.; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, China.; College of Basic Medical Science, China Three Gorges University, Yichang 443002, China.; Third-grade Pharmacological Laboratory on Traditional Chinese Medicine State Administration of Traditional Chinese Medicine, China Three Gorges University, China.; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, China.; College of Basic Medical Science, China Three Gorges University, Yichang 443002, China.; Third-grade Pharmacological Laboratory on Traditional Chinese Medicine State Administration of Traditional Chinese Medicine, China Three Gorges University, China.",False
40698150,High intensity forced ultrasound-driven ferroptosis as a strategy for anti-tumor immune priming.,Acta pharmaceutica Sinica. B,2025,Xuejing Li; Jiayi Wu; Ruizhe Xu; Xifeng Qin; Siyu Wang; Wuli Yang; Zhiqing Pang,"Key Laboratory of Smart Drug Delivery, School of Pharmacy, Fudan University, Shanghai 201203, China.; Key Laboratory of Smart Drug Delivery, School of Pharmacy, Fudan University, Shanghai 201203, China.; Key Laboratory of Smart Drug Delivery, School of Pharmacy, Fudan University, Shanghai 201203, China.; Key Laboratory of Smart Drug Delivery, School of Pharmacy, Fudan University, Shanghai 201203, China.; Key Laboratory of Smart Drug Delivery, School of Pharmacy, Fudan University, Shanghai 201203, China.; State Key Laboratory of Molecular Engineering of Polymers & Department of Macromolecular Science, Fudan University, Shanghai 200433, China.; Key Laboratory of Smart Drug Delivery, School of Pharmacy, Fudan University, Shanghai 201203, China.",False
40697533,Pembrolizumab monotherapy for previously treated metastatic HER2-negative breast cancer with germline APOBEC3B deletion: results of the phase II AUROR study.,The Lancet regional health. Western Pacific,2025,Gwo Fuang Ho; Soo Chin Lee; Anita Zarina Bustam; Adlinda Alip; Nur Fadhlina Abdul Satar; Marniza Saad; Rozita Abdul Malik; Siew Eng Lim; Samuel G W Ow; Andrea Wong; Wan-Qin Chong; Yvonne L E Ang; Audrey Weng Yan Lee; Siti Norhidayu Hasan; Nabilah Tuan Zaid; Kian Boon Law; Yok Yong Toh; Hooi Chiao Tan; Bawani Selvam; Joanna Lim; Jia-Wern Pan; Soo Hwang Teo,"Clinical Oncology Department, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; Department of Haematology-Oncology, National University Cancer Institute, Singapore.; Clinical Oncology Department, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; Clinical Oncology Department, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; Clinical Oncology Department, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; Clinical Oncology Department, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; Clinical Oncology Department, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; Department of Haematology-Oncology, National University Cancer Institute, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, Singapore.; Cancer Research Malaysia, Subang Jaya, Malaysia.; Cancer Research Malaysia, Subang Jaya, Malaysia.; Cancer Research Malaysia, Subang Jaya, Malaysia.; Institute for Clinical Research, Ministry of Health Malaysia, Setia Alam, Malaysia.; Universiti Malaya Medical Centre, Kuala Lumpur, Malaysia.; Universiti Malaya Medical Centre, Kuala Lumpur, Malaysia.; Cancer Research Malaysia, Subang Jaya, Malaysia.; Cancer Research Malaysia, Subang Jaya, Malaysia.; Cancer Research Malaysia, Subang Jaya, Malaysia.; Cancer Research Malaysia, Subang Jaya, Malaysia.",False
40697524,p62/SQSTM1 impairs immunotherapy in lung adenocarcinoma by suppressing immune infiltration and peripheral immune response.,Biochemistry and biophysics reports,2025,Haoran Li; Huamin Qin; Qinghan Xin; Jizhuo Gao; Shen Li; Aline M Thomas; Ning Li; Lingzhi Xu; Man Li,"Department of Breast Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.; Department of Pathology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.; Department of Breast Surgery, Dalian Municipal Central Hospital, Dalian, China.; Department of Breast Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.; Department of Neurology and Psychiatry, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.; The Russell H. Morgan Department of Radiology and Radiological Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Foreign Language, Dalian Medical University, Dalian, China.; Department of Breast Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.; Department of Breast Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.",False
40697412,Safety and toxicity risks of radiotherapy combined with PD-1/PD-L1 inhibitors: A comprehensive review.,iScience,2025,Lijing Zeng; Jing Yang; Huang Xia; Zeyuan Li; Yu Lin; Qiwei Yao; Rong Zheng,"Department of Radiation Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, P.R. China.; Department of Radiation Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, P.R. China.; Department of Radiation Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, P.R. China.; Department of Radiation Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, P.R. China.; Department of Radiation Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, P.R. China.; Department of Radiation Oncology, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.; Department of Radiation Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, P.R. China.; Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors (Fujian Medical University), Fuzhou, Fujian Province, P.R. China.; Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies), Fuzhou, Fujian Province, P.R. China.",True
40697319,Transformable self-assembling peptide nanoplatforms with tumor microenvironment responsiveness for tumor stem cell suppression and immunomodulation.,Materials today. Bio,2025,Chen Wei; Xinyu Sun; Lijuan Gao; Yue Wang; Fantao Lin; Yao Du; Xiaoyu Zhao; Wei Gao; Jingkun Bai,"Affiliated Hospital of Shandong Second Medical University, School of Medical Sciences, Shandong Second Medical University, Weifang, 261053, China.; Affiliated Hospital of Shandong Second Medical University, School of Medical Sciences, Shandong Second Medical University, Weifang, 261053, China.; Affiliated Hospital of Shandong Second Medical University, School of Bioscience and Technology, Shandong Second Medical University, Weifang, 261053, China.; Affiliated Hospital of Shandong Second Medical University, School of Medical Sciences, Shandong Second Medical University, Weifang, 261053, China.; Affiliated Hospital of Shandong Second Medical University, School of Medical Sciences, Shandong Second Medical University, Weifang, 261053, China.; Affiliated Hospital of Shandong Second Medical University, School of Bioscience and Technology, Shandong Second Medical University, Weifang, 261053, China.; Affiliated Hospital of Shandong Second Medical University, School of Medical Sciences, Shandong Second Medical University, Weifang, 261053, China.; Affiliated Hospital of Shandong Second Medical University, School of Medical Sciences, Shandong Second Medical University, Weifang, 261053, China.; Affiliated Hospital of Shandong Second Medical University, School of Bioscience and Technology, Shandong Second Medical University, Weifang, 261053, China.",False
40697217,Advances and challenges in drug repurposing in precision therapeutics of colorectal cancer.,World journal of gastrointestinal oncology,2025,Xin-Ning Yu; Hua-Tao Wu; Bing-Xuan Wu; Shu-Feng Zhi; Yang-Zheng Lan; Wen-Jia Chen; Jing Liu,"The Breast Center, Cancer Hospital of Shantou University Medical College, Shantou 515041, Guangdong Province, China.; Department of General Surgery, First Affiliated Hospital of Shantou University Medical College, Shantou 515041, Guangdong Province, China.; Department of General Surgery, First Affiliated Hospital of Shantou University Medical College, Shantou 515041, Guangdong Province, China.; Department of General Surgery, First Affiliated Hospital of Shantou University Medical College, Shantou 515041, Guangdong Province, China.; The Breast Center, Cancer Hospital of Shantou University Medical College, Shantou 515041, Guangdong Province, China.; The Breast Center, Cancer Hospital of Shantou University Medical College, Shantou 515041, Guangdong Province, China.; The Breast Center, Cancer Hospital of Shantou University Medical College, Shantou 515041, Guangdong Province, China. jliu12@stu.edu.cn.",False
40696947,Comprehensive analysis of an ATF/CREB family-based signature with regard to prognosis and immune feature in adrenocortical carcinoma: a cohort study.,"International journal of surgery (London, England)",2025,Kan Wu; Yige Jia; Yanxin Li; Jiayu Liang; Shengzhuo Liu; Yuchun Zhu; Xu Liu; Xiang Li; Zhihong Liu,"Department of Urology, Institute of Urology, West China Hospital, Sichuan University, chengdu, China.; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, chengdu, China.; Department of Urology, Institute of Urology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, chengdu, China.; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, chengdu, China.; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, chengdu, China.; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, chengdu, China.; Breast Center, West China Hospital, Sichuan University, China.; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, chengdu, China.; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, chengdu, China.",False
40696413,Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies.,Experimental hematology & oncology,2025,Ruoli Wang; Jincheng Zhuang; Qi Zhang; Wantao Wu; Xinrui Yu; Hao Zhang; Zongyi Xie,"Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.; Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.; Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.; Department of Thyroid and Breast Surgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.; Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.; Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. zhsw@hospital.cqmu.edu.cn.; Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. zyxie2008@cqmu.edu.cn.",False
40696096,"LncRNA NRAD1 regulates the triple-negative breast cancer transcriptome by miRNA biogenesis, localization, and predominately non-ceRNA interactions.",Scientific reports,2025,Hannah F Cahill; Justin M Brown; Manhattan Leslie-Toogood; Jaganathan Venkatesh; Marie-Claire D Wasson; Raj Pranap Arun; Meghan E McLean; Dejan Vidovic; Paola Marcato,"Department of Pathology, Dalhousie University, Rm 11C1, 5850 College Street, Halifax, NS, B3H 4R2, Canada.; Department of Pathology, Dalhousie University, Rm 11C1, 5850 College Street, Halifax, NS, B3H 4R2, Canada.; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.; Beatrice Hunter Cancer Research Institute, Dalhousie University, Halifax, NS, Canada.; Department of Pathology, Dalhousie University, Rm 11C1, 5850 College Street, Halifax, NS, B3H 4R2, Canada.; Beatrice Hunter Cancer Research Institute, Dalhousie University, Halifax, NS, Canada.; Department of Pathology, Dalhousie University, Rm 11C1, 5850 College Street, Halifax, NS, B3H 4R2, Canada.; Beatrice Hunter Cancer Research Institute, Dalhousie University, Halifax, NS, Canada.; Department of Pathology, Dalhousie University, Rm 11C1, 5850 College Street, Halifax, NS, B3H 4R2, Canada.; Beatrice Hunter Cancer Research Institute, Dalhousie University, Halifax, NS, Canada.; Department of Pathology, Dalhousie University, Rm 11C1, 5850 College Street, Halifax, NS, B3H 4R2, Canada.; Department of Surgery, Dalhousie University, Halifax, NS, Canada.; Nova Scotia Health Authority, Halifax, Canada.; Department of Pathology, Dalhousie University, Rm 11C1, 5850 College Street, Halifax, NS, B3H 4R2, Canada. paola.marcato@dal.ca.; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada. paola.marcato@dal.ca.; Beatrice Hunter Cancer Research Institute, Dalhousie University, Halifax, NS, Canada. paola.marcato@dal.ca.; Nova Scotia Health Authority, Halifax, Canada. paola.marcato@dal.ca.",False
40695812,MARCO expression on myeloid-derived suppressor cells is essential for their differentiation and immunosuppression.,Cell death discovery,2025,Sijia Liu; Binle Tian; Na Wang; Zhilong Wang; Wen Zhang; Qi Li; JianFei Wang; Guo-Huang Fan; Caicun Zhou,"Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.; Cancer Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Key Laboratory of Pancreatic Disease, Institute of Pancreatic Disease, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Department of Antibody Development, Immunophage Biotech Co., Ltd, Shanghai, China.; Department of Oncology, Immunophage Biotech Co., Ltd, Shanghai, China.; Department of Oncology, Immunophage Biotech Co., Ltd, Shanghai, China.; Cancer Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. leeqi@sjtu.edu.cn.; Shanghai Key Laboratory of Pancreatic Disease, Institute of Pancreatic Disease, Shanghai Jiao Tong University School of Medicine, Shanghai, China. leeqi@sjtu.edu.cn.; Executive Office, Immunophage Biotech Co., Ltd, Shanghai, China. jfwang@immunophage.com.cn.; Shanghai Laboratory Animal Research Center, Shanghai, China. jfwang@immunophage.com.cn.; Executive Office, Immunophage Biotech Co., Ltd, Shanghai, China. ghfan@immunophage.com.cn.; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. caicunzhoudr@163.com.; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China. caicunzhoudr@163.com.",True
40695078,Oxygen-boosted nanodrug for amplified ferroptosis-photodynamic immunotherapy together with PD-1 checkpoint blockade against triple-negative breast cancer.,"Colloids and surfaces. B, Biointerfaces",2025,Zhirong Yang; Lingli Deng; Zhenhong Pan; Xiaoyang Wang; Li Lin; Yaqi Fang; Yinxing Huang; Xianquan Feng; Xi Chen,"Department of Oncology, Fuzong Teaching Hospital of Fujian University of Traditional Chinese Medicine (900th Hospital of PLA Joint Logistics Support Force), Fuzong Clinical Medical College of Fujian Medical University, Fuzhou 350025, China.; Departmentof Traditional Chinese Medicine, 900th Hospital of PLA Joint Logistics Support Force, Fuzhou 350025, China.; Department of Neurosurgery, Fuzong Teaching Hospital of Fujian University of TraditionalChinese Medicine (900th Hospital of PLA Joint Logistics Support Force), Fuzong Clinical Medical College of Fujian Medical University, Fuzhou 350025, China.; Department of Oncology, Fuzong Teaching Hospital of Fujian University of Traditional Chinese Medicine (900th Hospital of PLA Joint Logistics Support Force), Fuzong Clinical Medical College of Fujian Medical University, Fuzhou 350025, China.; Department of Oncology, Fuzong Teaching Hospital of Fujian University of Traditional Chinese Medicine (900th Hospital of PLA Joint Logistics Support Force), Fuzong Clinical Medical College of Fujian Medical University, Fuzhou 350025, China.; School of Computing and Information Science, Fuzhou Institute of Technology, Fuzhou 350118, China.; Department of Neurosurgery, Fuzong Teaching Hospital of Fujian University of TraditionalChinese Medicine (900th Hospital of PLA Joint Logistics Support Force), Fuzong Clinical Medical College of Fujian Medical University, Fuzhou 350025, China.; Laboratory of Basic Medicine, Fuzong Teaching Hospital of Fujian University of Traditional Chinese Medicine (900th Hospital of PLA Joint Logistics Support Force), Fuzong Clinical Medical College of Fujian Medical University, Fuzhou 350025, China. Electronic address: 904397623@qq.com.; Department of Oncology, Fuzong Teaching Hospital of Fujian University of Traditional Chinese Medicine (900th Hospital of PLA Joint Logistics Support Force), Fuzong Clinical Medical College of Fujian Medical University, Fuzhou 350025, China. Electronic address: fuzhoucxi@163.com.",False
40694938,Chrono-controlled hydrogel platform orchestrates metabolic reprogramming and cuproptosis-driven immune activation against triple-negative breast cancer.,Biomaterials,2025,Yao Lu; Qingqing Pan; Kui Luo; Bin He; Yuji Pu,"National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu, 610064, China.; School of Preclinical Medicine, Chengdu University, Chengdu, 610106, China.; Huaxi MR Research Center (HMRRC), Department of Radiology, West China Hospital, Functional and molecular imaging Key Laboratory of Sichuan Province, Sichuan University, Chengdu, 610041, China.; National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu, 610064, China.; National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu, 610064, China. Electronic address: yjpu@scu.edu.cn.",False
40694271,The role of LAMA5 in breast cancer progression and its potential in immunotherapy.,Discover oncology,2025,Xiaoli Zhang; Hongfang Yan; Lihan Bie; Zheng Xu; Xiaoyang Yao; Zhilan Li; Chengshan He; Zhouhong Xiang; Xiudi Jiang,"Department of Clinical Laboratory, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, 358 Da TongRoad, Pudong New Area, Shanghai, 200137, PR China.; Department of Clinical Laboratory, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, 358 Da TongRoad, Pudong New Area, Shanghai, 200137, PR China.; Department of Clinical Laboratory, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, 358 Da TongRoad, Pudong New Area, Shanghai, 200137, PR China.; Department of Clinical Laboratory, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, 358 Da TongRoad, Pudong New Area, Shanghai, 200137, PR China.; Department of Clinical Laboratory, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, 358 Da TongRoad, Pudong New Area, Shanghai, 200137, PR China.; Department of Clinical Laboratory, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, 358 Da TongRoad, Pudong New Area, Shanghai, 200137, PR China.; Department of Clinical Laboratory, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, 358 Da TongRoad, Pudong New Area, Shanghai, 200137, PR China.; Department of Clinical Laboratory, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, 358 Da TongRoad, Pudong New Area, Shanghai, 200137, PR China. scythia@126.com.; Department of Clinical Laboratory, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, 358 Da TongRoad, Pudong New Area, Shanghai, 200137, PR China. jiangxd1219@163.com.",False
40693728,Pneumonitis induced by immune checkpoint inhibitors: a systematic review.,Expert review of respiratory medicine,2025,Ana Casal; Virginia Leiro; Laura Villar; Manuel Casal-Guisande; Cristina Pou; Mar Mosteiro; Maribel Botana; Tamara Lourido; María Castro; María Torres-Durán; Alberto Fernández-Villar,"Pulmonary Department, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain.; NeumoVigo I+i Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.; Pulmonary Department, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain.; NeumoVigo I+i Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.; Centro de Investigación Biomédica en Red, CIBERES ISCIII, Madrid, Spain.; Pulmonary Department, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain.; NeumoVigo I+i Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.; NeumoVigo I+i Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.; Centro de Investigación Biomédica en Red, CIBERES ISCIII, Madrid, Spain.; Fundación Pública Galega de Investigación Biomédica Galicia Sur, Hospital Álvaro Cunqueiro, Vigo, Spain.; Pulmonary Department, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain.; NeumoVigo I+i Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.; Pulmonary Department, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain.; NeumoVigo I+i Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.; Pulmonary Department, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain.; NeumoVigo I+i Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.; Centro de Investigación Biomédica en Red, CIBERES ISCIII, Madrid, Spain.; Pulmonary Department, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain.; Pulmonary Department, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain.; Pulmonary Department, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain.; NeumoVigo I+i Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.; Centro de Investigación Biomédica en Red, CIBERES ISCIII, Madrid, Spain.; Pulmonary Department, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain.; NeumoVigo I+i Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.; Centro de Investigación Biomédica en Red, CIBERES ISCIII, Madrid, Spain.; School of Industrial Engineering, University of Vigo, Vigo, Spain.",False
40692392,Targeted Delivery of miR-34a via Anti-CD47 Antibody Conjugates for Enhanced Cancer Immunotherapy in Triple Negative Breast Cancer.,"Small (Weinheim an der Bergstrasse, Germany)",2025,Youngri Ryu; Eun Hye Kim; Hochung Jang; Yelee Kim; Byeongmin Park; Jiwoong Choi; Yeongji Jang; Sung-Gil Chi; Man Kyu Shim; Sun Hwa Kim; Hong Yeol Yoon; Yoosoo Yang,"Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, 16419, Republic of Korea.; Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, 16419, Republic of Korea.; Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, 16419, Republic of Korea.; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, 02841, Republic of Korea.; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.; Department of Life Sciences, Korea University, Seoul, 02841, Republic of Korea.; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, 02841, Republic of Korea.; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.; Division of Bio-Medical Science and Technology, KIST School, University of Science and Technology, Seoul, 02792, Republic of Korea.; Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, 16419, Republic of Korea.",False
40692275,Targeting CDK2 and other novel cell cycle targets for breast cancer therapy.,Expert opinion on therapeutic targets,2025,Mei-Kuang Chen; Linjie Luo; Nicole Massoumi; Khandan Keyomarsi,"Department of Experimental Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Experimental Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Experimental Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Bioengineering, Yale University, New Haven, CT, USA.; Department of Experimental Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.",False
40691737,Intersection of ferroptosis and nanomaterials brings benefits to breast cancer.,Cell biology and toxicology,2025,Jian Gao; Ningye Ma; Sha Ni; Xue Han,"Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning, China.; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning, China.; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning, China. carolnisha@sina.com.; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning, China. cindy88420@163.com.",False
40691137,Molecular features of TNBC govern heterogeneity in the response to radiation and autophagy inhibition.,Cell death & disease,2025,Patrick Fischer; Maximilian Schmid; Anna Ohradanova-Repic; Rebecca Schneeweiss; Jana Hadatsch; Odysseus Grünert; Johannes Benedum; Anna Röhrer; Felix Staudinger; Philipp Schatzlmaier; Niccolo Bragato; Sandra Barna; Magdalena Engl; Ava Kleinwächter; Dietmar Georg; Joachim Widder; Sylvia Kerschbaum-Gruber; Dea Slade,"Department of Radiation Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.; Max Perutz Labs, Vienna Biocenter Campus (VBC), Dr.-Bohr-Gasse 9, 1030, Vienna, Austria.; Medical University of Vienna, Center for Medical Biochemistry, Dr.-Bohr-Gasse 9, 1030, Vienna, Austria.; MedAustron Ion Therapy Center, Wiener Neustadt, Austria.; Department of Radiation Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.; Max Perutz Labs, Vienna Biocenter Campus (VBC), Dr.-Bohr-Gasse 9, 1030, Vienna, Austria.; Medical University of Vienna, Center for Medical Biochemistry, Dr.-Bohr-Gasse 9, 1030, Vienna, Austria.; MedAustron Ion Therapy Center, Wiener Neustadt, Austria.; Medical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Institute for Hygiene and Applied Immunology, Lazarettgasse 19, 1090, Vienna, Austria.; Max Perutz Labs, Vienna Biocenter Campus (VBC), Dr.-Bohr-Gasse 9, 1030, Vienna, Austria.; Medical University of Vienna, Center for Medical Biochemistry, Dr.-Bohr-Gasse 9, 1030, Vienna, Austria.; Max Perutz Labs, Vienna Biocenter Campus (VBC), Dr.-Bohr-Gasse 9, 1030, Vienna, Austria.; Medical University of Vienna, Center for Medical Biochemistry, Dr.-Bohr-Gasse 9, 1030, Vienna, Austria.; Max Perutz Labs, Vienna Biocenter Campus (VBC), Dr.-Bohr-Gasse 9, 1030, Vienna, Austria.; Medical University of Vienna, Center for Medical Biochemistry, Dr.-Bohr-Gasse 9, 1030, Vienna, Austria.; Max Perutz Labs, Vienna Biocenter Campus (VBC), Dr.-Bohr-Gasse 9, 1030, Vienna, Austria.; Medical University of Vienna, Center for Medical Biochemistry, Dr.-Bohr-Gasse 9, 1030, Vienna, Austria.; Vienna Biocenter PhD Program, a Doctoral School of the University of Vienna and the Medical University of Vienna, 1030, Vienna, Austria.; Department of Radiation Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.; MedAustron Ion Therapy Center, Wiener Neustadt, Austria.; Department of Radiation Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.; MedAustron Ion Therapy Center, Wiener Neustadt, Austria.; Medical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Institute for Hygiene and Applied Immunology, Lazarettgasse 19, 1090, Vienna, Austria.; Department of Radiation Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.; MedAustron Ion Therapy Center, Wiener Neustadt, Austria.; Department of Radiation Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.; Max Perutz Labs, Vienna Biocenter Campus (VBC), Dr.-Bohr-Gasse 9, 1030, Vienna, Austria.; Medical University of Vienna, Center for Medical Biochemistry, Dr.-Bohr-Gasse 9, 1030, Vienna, Austria.; Vienna Biocenter PhD Program, a Doctoral School of the University of Vienna and the Medical University of Vienna, 1030, Vienna, Austria.; Max Perutz Labs, Vienna Biocenter Campus (VBC), Dr.-Bohr-Gasse 9, 1030, Vienna, Austria.; Medical University of Vienna, Center for Medical Biochemistry, Dr.-Bohr-Gasse 9, 1030, Vienna, Austria.; Vienna Biocenter PhD Program, a Doctoral School of the University of Vienna and the Medical University of Vienna, 1030, Vienna, Austria.; Department of Radiation Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.; MedAustron Ion Therapy Center, Wiener Neustadt, Austria.; Department of Radiation Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.; Department of Radiation Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.; MedAustron Ion Therapy Center, Wiener Neustadt, Austria.; Department of Radiation Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. dea.slade@meduniwien.ac.at.; Comprehensive Cancer Center, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria. dea.slade@meduniwien.ac.at.; Max Perutz Labs, Vienna Biocenter Campus (VBC), Dr.-Bohr-Gasse 9, 1030, Vienna, Austria. dea.slade@meduniwien.ac.at.; Medical University of Vienna, Center for Medical Biochemistry, Dr.-Bohr-Gasse 9, 1030, Vienna, Austria. dea.slade@meduniwien.ac.at.; MedAustron Ion Therapy Center, Wiener Neustadt, Austria. dea.slade@meduniwien.ac.at.",False
40690171,Pre-Treatment Tumor Collagen is Associated with Triple-Negative Breast Cancer Pathological Response to Chemo-Immunotherapy.,Annals of surgical oncology,2025,Mackenzie Jones; Zahraa W Alsafwani; Javier I J Orozco; Subodh M Lele; Mohd Wasim Nasser; Surinder K Batra; Juan A Santamaria-Barria,"Department of Surgery, University of Nebraska Medical Center, Omaha, NE, USA. mackjones14@gmail.com.; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, USA.; Department of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, NE, USA.; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.; Division of Surgical Oncology, Department of Surgery, University of Nebraska Medical Center, Omaha, NE, USA.",False
40689866,Timing of Recurrence After Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer.,Clinical cancer research : an official journal of the American Association for Cancer Research,2025,Luca Licata; Marco Mariani; Giulia Viale; Rebecca Dent; Sara M Tolaney; Peter Schmid; Erika Hamilton; Christos Sotiriou; Lajos Pusztai; Giampaolo Bianchini,"IRCCS Ospedale San Raffaele, Milan, Italy.; IRCCS Ospedale San Raffaele, Milan, Italy.; IRCCS Ospedale San Raffaele, Milan, Italy.; National Cancer Centre, Singapore, Singapore.; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Barts Cancer Institute, London, United Kingdom.; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, Tennessee, United States.; Institut Jules Bordet, Brussels, Belgium.; Yale University, New Haven, United States.; IRCCS Ospedale San Raffaele, Milan, Italy.",False
40688661,A MnO2-based tumor-seeking nanoplatform for enhanced chemoimmunotherapy against 4T1 breast cancer.,Materials today. Bio,2025,Tingting Gong; Xiaohuan Wang; Ziqi Liu; Pengxin Li; Yunqian Lu; Yaoyao Guo; Meihua Han; Xiangtao Wang,"Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing 100193, China.; Research Center of Pharmaceutical Engineering Technology, Harbin University of Commerce, Harbin, Heilongjiang province, 150076, China.; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing 100193, China.; School of Pharmacy, Henan University of Chinese Medicine, Henan province, 450046, China.; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing 100193, China.; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing 100193, China.; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing 100193, China.; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing 100193, China.",False
40688509,The HER2 target for designing novel multi-peptide vaccine against breast cancer using immunoinformatics and molecular dynamic simulation.,Biochemistry and biophysics reports,2025,Faezeh Firuzpour; Maryam Barancheshmeh; Fariba Fallah Ziarani; Leila Karami; Cena Aram,"Student Research Committee, Babol University of Medical Sciences, Babol, Iran.; USERN Office, Babol University of Medical Sciences, Babol, Iran.; Universal Scientific Education and Research Network (USERN), Nowshahr, Iran.; Department of Computer Engineering, Raja University, Qazvin, Iran.; Department of Cell & Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.; Department of Computer Engineering, Raja University, Qazvin, Iran.",False
40688079,Immunomodulatory effects of photothermal therapy in breast cancer: advances and challenges.,Frontiers in immunology,2025,Lin Chen; Hanyu Zhang; Yi Hou; Wang Yunlong; Xianhu Feng,"Nanchong Key Laboratory of Individualized Drug Therapy, Department of Pharmacy, Beijing Anzhen Nanchong Hospital Capital Medical University & Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong, Sichuan, China.; Nanchong Key Laboratory of Individualized Drug Therapy, Department of Pharmacy, Beijing Anzhen Nanchong Hospital Capital Medical University & Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong, Sichuan, China.; Clinical Pharmacy and Pharmacy Department of The People's Hospital of Zhongjiang, Deyang, Sichuan, China.; Nanchong Key Laboratory of Individualized Drug Therapy, Department of Pharmacy, Beijing Anzhen Nanchong Hospital Capital Medical University & Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong, Sichuan, China.; Nanchong Key Laboratory of Individualized Drug Therapy, Department of Pharmacy, Beijing Anzhen Nanchong Hospital Capital Medical University & Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong, Sichuan, China.",False
40687225,Construction of a novel disulfidptosis-associated lncRNAs signature for risk features and immunotherapy in breast cancer.,Translational cancer research,2025,Jun Zhou; Yongfei Li; Jiangtao Wang; Ming Feng; Chang Yao,"Department of Mastopathy, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.; Department of Mastopathy, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.; Department of Mastopathy, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.; Department of Mastopathy, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.; Department of Mastopathy, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.",False
40685871,Immunotherapy and combination treatments for triple-negative breast cancer: a Scopus bibliometric perspective.,"Future oncology (London, England)",2025,Ninie Nadia Zulkipli; Imilia Ismail; Wan Rohani Wan Taib; Sarina Sulong,"Human Genome Centre, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia.; School of Biomedicine, Faculty of Health Sciences, Universiti Sultan Zainal Abidin, Terengganu, Malaysia.; School of Biomedicine, Faculty of Health Sciences, Universiti Sultan Zainal Abidin, Terengganu, Malaysia.; School of Biomedicine, Faculty of Health Sciences, Universiti Sultan Zainal Abidin, Terengganu, Malaysia.; Human Genome Centre, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia.",False
40684936,Reinforced immunotherapy of M1 macrophage-derived exosomes with CEL on TNBC via regulating macrophage functions.,Journal of advanced research,2025,Liuchunyang Yu; Xinyi Luo; Zhengjia Zhang; Xiaoyu Li; Meng Tian; JinXiu Qian; Jue Yang; Rongjun Deng; Xiuyun Bai; Cheng Lu; Aiping Lu; Yuanyan Liu,"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijin, China.; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijin, China.; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijin, China.; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijin, China.; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijin, China.; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijin, China.; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijin, China.; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijin, China.; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijin, China.; Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China. Electronic address: lv_cheng0816@163.com.; School of Chinese Medicine, Hong Kong Baptist University, Kowloon, Hongkong, China. Electronic address: aipinglu@hkbu.edu.hk.; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijin, China. Electronic address: yyliu_1980@163.com.",False
40684868,Targeting hormone-related signals to reprogram the antitumor immune response in breast cancer: Research progress and application prospects.,Biochimica et biophysica acta. Reviews on cancer,2025,Shunchao Yan; Zhijie Zhang; Jiale Ji; Murshid Imam; Simiao Wang,"Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110022, China. Electronic address: yansc@cmu.edu.cn.; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110022, China.; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110022, China.; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110022, China.; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110022, China.",False
40684017,Predictors of Nodal Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer.,Annals of surgical oncology,2025,Selena J An; Christine Hong Ngoc Che Thai; Chris B Agala; Yara G Abdou; Julia M Selfridge; Philip M Spanheimer,"Department of Surgery, University of North Carolina, Chapel Hill, NC, USA.; Department of Surgery, University of North Carolina, Chapel Hill, NC, USA.; Department of Surgery, University of North Carolina, Chapel Hill, NC, USA.; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.; Department of Surgery, University of North Carolina, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; Department of Surgery, University of North Carolina, Chapel Hill, NC, USA. Philip_Spanheimer@med.unc.edu.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. Philip_Spanheimer@med.unc.edu.; Department of Genetics, University of North Carolina, Chapel Hill, NC, USA. Philip_Spanheimer@med.unc.edu.",False
40683683,Phenotypic assessment of dendritic cell maturation by cost-effective custom ELISA assays.,Methods in cell biology,2025,Peng Liu; Yuhong Pan; Misha Mao; Guido Kroemer; Oliver Kepp; Liwei Zhao,"Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France; Department of Breast Surgery, Zhejiang Provincial People's Hospital, Hangzhou, P.R. China.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France; Institut du Cancer Paris CARPEM, Department of Biology, APHP, Hôpital Européen Georges Pompidou, Paris, France. Electronic address: kroemer@orange.fr.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France. Electronic address: captain.olsen@gmail.com.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France. Electronic address: liweizhaol@gmail.com.",False
40683100,Development of a novel multi-epitope vaccine against triple-negative breast cancer targeting A-kinase anchoring protein 3 using bioinformatics.,Computers in biology and medicine,2025,Zahrotun Nafiah; Navista Sri Octa Ujiantari; Badra Sanditya Rattyananda; Setyowati Triastuti Utami; Ratna Surya Alwi; Adam Hermawan,"Laboratory of Macromolecular Engineering, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada Sekip Utara II, 55281, Yogyakarta, Indonesia.; Laboratory of Medicinal Chemistry, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara II, 55281, Yogyakarta, Indonesia.; Research Centre for Computation, Research Organization for Electronics and Informatics, National Research and Innovation Agency (BRIN), Jl. Tamansari 71, Bandung City, 40132, Indonesia; Doctoral Program of Computational Science, Division of Mathematical & Physical Sciences, Graduate School of Science & Technology, Kanazawa University, Kakuma, Kanazawa, Ishikawa, 920-1192, Japan.; Laboratory of Macromolecular Engineering, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada Sekip Utara II, 55281, Yogyakarta, Indonesia.; Research Centre for Computing, National Research and Innovation Agency (BRIN), Jl. Raya Jakarta-Bogor KM 46 Cibinong, 16911, Indonesia.; Laboratory of Macromolecular Engineering, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada Sekip Utara II, 55281, Yogyakarta, Indonesia; Laboratory of Advanced Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara II, 55281, Yogyakarta, Indonesia. Electronic address: adam_apt@ugm.ac.id.",False
40683070,In-depth review of breast cancer and inflammation pre-and post-treatment strategies with conventional and novel Steroid agents.,Advances in biological regulation,2025,Panneerselvam Theivendren; Punitha Narayanasamy; Kumarappan Chidamabaram; Sangeetha Menon; Josephin Arockia Dhivya Antony Sahayaraj; Natarajan Kiruthiga; Balaji Pandiyan,"Department of Pharmaceutical Chemistry & Analysis, School of Pharmaceutical Sciences, Vels Institute of Science, Technology & Advanced Studies, Pallavaram, Chennai, Tamil Nadu, 600117, India. Electronic address: tpsphc@gmail.com.; Department of Physics, St. Joseph's College of Engineering, OMR, Chennai, Tamil Nadu, 600119, India.; Department of Pharmacology, College of Pharmacy, King Khalid University, Abha, 61421, Asir Province, Saudi Arabia.; Department of Life Sciences, Kristu Jayanti College Autonomous, Bengaluru, Karnataka, 560077, India.; Department of Biomedical Engineering, Vels Institute of Science, Technology & Advanced Studies, Pallavaram, Chennai, Tamil Nadu, 600117, India.; Department of Pharmaceutical Chemistry, KMCH College of Pharmacy, Kalappatti Road, Coimbatore, Tamil Nadu, 641048, India.; Department of Pharmacology, School of Pharmaceutical Sciences, Vels Institute of Science, Technology & Advanced Studies, Pallavaram, Chennai, Tamil Nadu, 600117, India.",False
40681176,Therapeutic potential of T-cell receptor targeting the HLA-A*11:01-restricted KRASG12V neoantigen without cross-recognition of the self-antigen RAB7B in solid tumors.,Journal for immunotherapy of cancer,2025,Meiying Shen; Yanan Hao; Xiaxia Han; Bozhi Wang; Luo Li; Tong Chen; Siyin Chen; Lin Zou; Jingjing Huang; Wang Wang; Shengchun Liu; Xiaojian Han; Aishun Jin,"Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Chongqing Key Laboratory of Tumor Immune Regulation and Immune Intervention, Chongqing Medical University, Chongqing, China.; Chongqing Key Laboratory of Tumor Immune Regulation and Immune Intervention, Chongqing Medical University, Chongqing, China.; Department of Immunology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.; Chongqing Key Laboratory of Tumor Immune Regulation and Immune Intervention, Chongqing Medical University, Chongqing, China.; Department of Immunology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.; Chongqing Key Laboratory of Tumor Immune Regulation and Immune Intervention, Chongqing Medical University, Chongqing, China.; Department of Immunology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.; Chongqing Key Laboratory of Tumor Immune Regulation and Immune Intervention, Chongqing Medical University, Chongqing, China.; Department of Immunology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.; Chongqing Key Laboratory of Tumor Immune Regulation and Immune Intervention, Chongqing Medical University, Chongqing, China.; Department of Immunology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.; Chongqing Key Laboratory of Tumor Immune Regulation and Immune Intervention, Chongqing Medical University, Chongqing, China.; Department of Immunology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.; Chongqing Key Laboratory of Tumor Immune Regulation and Immune Intervention, Chongqing Medical University, Chongqing, China.; Department of Immunology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.; Chongqing Key Laboratory of Tumor Immune Regulation and Immune Intervention, Chongqing Medical University, Chongqing, China.; Department of Immunology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.; Chongqing Key Laboratory of Tumor Immune Regulation and Immune Intervention, Chongqing Medical University, Chongqing, China.; Department of Immunology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.; Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Chongqing Key Laboratory of Tumor Immune Regulation and Immune Intervention, Chongqing Medical University, Chongqing, China.; Chongqing Key Laboratory of Tumor Immune Regulation and Immune Intervention, Chongqing Medical University, Chongqing, China aishunjin@cqmu.edu.cn xiaojianhan1989@163.com.; Department of Immunology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.; Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China aishunjin@cqmu.edu.cn xiaojianhan1989@163.com.; Chongqing Key Laboratory of Tumor Immune Regulation and Immune Intervention, Chongqing Medical University, Chongqing, China.; Department of Immunology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.",False
40680742,A stratification system for breast cancer based on basoluminal tumor cells and spatial tumor architecture.,Cancer cell,2025,Lasse Meyer; Hartland W Jackson; Nils Eling; Shan Zhao; Genki Usui; Haithem Dakhli; Peter Schraml; Susanne Dettwiler; Constanze Elfgen; Zsuzsanna Varga; Holger Moch; Natalie de Souza; Bernd Bodenmiller,"Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland; Institute for Molecular Health Sciences, ETH Zurich, Zurich, Switzerland; Life Science Zurich Graduate School, ETH Zurich/University of Zurich, Zurich, Switzerland.; Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.; Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland; Institute for Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.; Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland; Institute for Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.; Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland; Institute for Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.; Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland; Institute for Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.; Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland.; Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland.; Breast-Center Zurich, Zurich, Switzerland; Department of Medicine, University of Witten-Herdecke, Witten, Germany.; Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland.; Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland.; Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland; Institute for Molecular Health Sciences, ETH Zurich, Zurich, Switzerland; Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.; Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland; Institute for Molecular Health Sciences, ETH Zurich, Zurich, Switzerland. Electronic address: bernd.bodenmiller@uzh.ch.",False
40680555,Layered double hydroxide-delivered si-NEAT1 inhibits breast cancer immune evasion and malignant progression by modulating the miR-141-3p/PD-L1 axis.,Bioorganic chemistry,2025,Yuhan Xiao; Ruorong Ran; Chengle Zhu; Yuxin Ji; Jiwen Shi; Ruyin Ye; Chenchen Geng; Ruonan Li; Guohui Tang; Wenrui Wang; Qingling Yang; Changjie Chen,"Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu medical university, Anhui 233030, China; Clinical Testing and Diagnose Experimental Center, Bengbu Medical University, Anhui 233030, China.; Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu medical university, Anhui 233030, China.; Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu medical university, Anhui 233030, China; Clinical Testing and Diagnose Experimental Center, Bengbu Medical University, Anhui 233030, China.; Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu medical university, Anhui 233030, China; Clinical Testing and Diagnose Experimental Center, Bengbu Medical University, Anhui 233030, China.; Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu medical university, Anhui 233030, China.; Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu medical university, Anhui 233030, China.; Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu medical university, Anhui 233030, China.; Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu medical university, Anhui 233030, China; Clinical Testing and Diagnose Experimental Center, Bengbu Medical University, Anhui 233030, China.; Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu medical university, Anhui 233030, China.; Department of Life Sciences, Bengbu Medical University, Anhui 233030, China. Electronic address: wenrui-wang1983@163.com.; Department of Biochemistry and Molecular Biology, Bengbu Medical University, Anhui 233030, China; Nstitute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, Anhui, China. Electronic address: yqlmimi@163.com.; Department of Biochemistry and Molecular Biology, Bengbu Medical University, Anhui 233030, China. Electronic address: tochenchangjie@163.com.",False
40680539,RC48-targeted two-dimensional black phosphorus nanoplatform for precise photothermal-immunotherapy of HER2-positive breast cancer.,Journal of colloid and interface science,2025,Feiyang Xiao; Guanyuan Chen; Hongwei Lu; Xinrui Li; Shuzhao Chen; Ziyang Lin; Wenxiu Ni; Ruiqian Yang; Xinqiang Fang; Haoyu Lin; Benqing Zhou; Yuanke Liang,"Department of Biomedical Engineering, College of Engineering, Shantou University, Shantou 515063, China.; Department of Thyroid and Breast Surgery, Clinical Research Center, The First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China; Department of Chemistry, The University of Hong Kong, Hong Kong 999077, China.; Department of Biomedical Engineering, College of Engineering, Shantou University, Shantou 515063, China.; Department of Biomedical Engineering, College of Engineering, Shantou University, Shantou 515063, China.; Department of Thyroid and Breast Surgery, Clinical Research Center, The First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China.; Department of Medical Oncology, Cancer Hospital of Shantou University Medical College, Shantou 515031, China.; Department of Thyroid and Breast Surgery, Clinical Research Center, The First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China.; Department of Thyroid and Breast Surgery, Clinical Research Center, The First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China.; Department of Thyroid and Breast Surgery, Clinical Research Center, The First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China.; Department of Thyroid and Breast Surgery, Clinical Research Center, The First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China; Human Phenome Institute of Shantou University Medical College, Guangdong Engineering Research Centre of Human Phenome, Chemistry and Chemical Engineering Guangdong, Shantou 515000, China. Electronic address: rainlhy@stu.edu.cn.; Department of Biomedical Engineering, College of Engineering, Shantou University, Shantou 515063, China. Electronic address: bqzhou@stu.edu.cn.; Department of Thyroid and Breast Surgery, Clinical Research Center, The First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China; Human Phenome Institute of Shantou University Medical College, Guangdong Engineering Research Centre of Human Phenome, Chemistry and Chemical Engineering Guangdong, Shantou 515000, China. Electronic address: 07ykliang1@stu.edu.cn.",False
40680158,Predicting Pathological Complete Response Following Neoadjuvant Therapy in Patients With Breast Cancer: Development of Machine Learning-Based Prediction Models in a Retrospective Study.,JMIR cancer,2025,Chun-Chi Lai; Cheng-Yu Chen; Tzu-Hao Chang,"Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, 9th Floor, 301 Yuantong Road, Zhonghe District, Taipei, Taiwan, 886 66202589 ext 10928.; Division of General Surgery, Department of Surgery, New Taipei Municipal TuCheng Hospital, New Taipei City, Taiwan.; Department of Medical Imaging, Taipei Medical University Hospital, Taipei, Taiwan.; Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Research Center for Artificial Intelligence in Medicine, Taipei Medical University, Taipei, Taiwan.; Department of Radiology, National Defense Medical Center, Taipei, Taiwan.; Translational Imaging Research Center, Taipei Medical University Hospital, Taipei, Taiwan.; Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, 9th Floor, 301 Yuantong Road, Zhonghe District, Taipei, Taiwan, 886 66202589 ext 10928.; Clinical Big Data Research Center, Taipei Medical University Hospital, Taipei, Taiwan.",False
40680115,Temporally programmed STING nanoadjuvant delivery unlocks synergistic chemotherapy-induced antitumor immunity.,Science advances,2025,Zimeng Yang; Hengzhi Liu; Shuo Li; Zhaochu Xu; Wenxiao Li; Yubo Liu; Qingzhi Lv; Hongzhuo Liu; Zhonggui He; Yongjun Wang,"Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.; School of Pharmacy, Binzhou Medical University, Yantai 264003, China.; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.; Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.; Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.; Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.",False
40679093,Targeting IGF1R Overcomes Armored and Cold Tumor Microenvironment and Boosts Immune Checkpoint Blockade in Triple-Negative Breast Cancer.,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",2025,Mengyun Wan; Jie Mei; Yun Cai; Ji Zhou; Ningyi Xue; Ying Jiang; Yan Zhang; Jingjing Huang; Yichao Zhu,"Department of Physiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, 211166, China.; The First Clinical Medicine College, Nanjing Medical University, Nanjing, Jiangsu, 211166, China.; Department of Central Laboratory, The First People's Hospital of Jintan, Jintan Affiliated Hospital of Jiangsu University, Changzhou, Jiangsu, 213251, China.; Department of Physiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, 211166, China.; The First Clinical Medicine College, Nanjing Medical University, Nanjing, Jiangsu, 211166, China.; Departments of Gynecology, Wuxi Maternity and Child Health Care Hospital, Affiliated Women's Hospital of Jiangnan University, Wuxi, Jiangsu, 214023, China.; Departments of Gynecology, Wuxi Maternity and Child Health Care Hospital, Affiliated Women's Hospital of Jiangnan University, Wuxi, Jiangsu, 214023, China.; Departments of Gynecology, Wuxi Maternal and Child Health Care Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, 214023, China.; Department of Geriatrics, The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 211800, China.; Department of Physiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, 211166, China.; Department of General Surgery, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, Jiangsu, 214504, China.",False
